

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Looking at the recent advances in understanding... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-525/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-525" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform prism" />
    
            <meta name="og:title" content="F1000Research Article: Looking at the recent advances in understanding &alpha;-synuclein and its aggregation through the proteoform prism.">
            <meta name="og:description" content="Read the latest article version by Vladimir N. Uversky, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11354">
            <meta name="article-id" content="10536">
            <meta name="dc.title" content="Looking at the recent advances in understanding &alpha;-synuclein and its aggregation through the proteoform prism">
            <meta name="dc.description" content="Despite attracting the close attention of multiple researchers for the past 25 years, &alpha;-synuclein continues to be an enigma, hiding sacred truth related to its structure, function, and dysfunction, concealing mechanisms of its pathological spread within the affected brain during disease progression, and, above all, covering up the molecular mechanisms of its multipathogenicity, i.e. the ability to be associated with the pathogenesis of various diseases. The goal of this article is to present the most recent advances in understanding of this protein and its aggregation and to show that the remarkable structural, functional, and dysfunctional multifaceted nature of &alpha;-synuclein can be understood using the proteoform concept.">
            <meta name="dc.subject" content="&alpha;-synuclein, aggregation, synucleinopathies, multifunctionality">
            <meta name="dc.creator" content="Uversky, Vladimir N.">
            <meta name="dc.date" content="2017/04/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10536.1">
            <meta name="dc.source" content="F1000Research 2017 6:525">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="&alpha;-synuclein ">
            <meta name="prism.keyword" content=" aggregation ">
            <meta name="prism.keyword" content=" synucleinopathies ">
            <meta name="prism.keyword" content=" multifunctionality">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/04/20">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="525">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10536.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-525">
            <meta name="citation_title" content="Looking at the recent advances in understanding &alpha;-synuclein and its aggregation through the proteoform prism">
            <meta name="citation_abstract" content="Despite attracting the close attention of multiple researchers for the past 25 years, &alpha;-synuclein continues to be an enigma, hiding sacred truth related to its structure, function, and dysfunction, concealing mechanisms of its pathological spread within the affected brain during disease progression, and, above all, covering up the molecular mechanisms of its multipathogenicity, i.e. the ability to be associated with the pathogenesis of various diseases. The goal of this article is to present the most recent advances in understanding of this protein and its aggregation and to show that the remarkable structural, functional, and dysfunctional multifaceted nature of &alpha;-synuclein can be understood using the proteoform concept.">
            <meta name="citation_description" content="Despite attracting the close attention of multiple researchers for the past 25 years, &alpha;-synuclein continues to be an enigma, hiding sacred truth related to its structure, function, and dysfunction, concealing mechanisms of its pathological spread within the affected brain during disease progression, and, above all, covering up the molecular mechanisms of its multipathogenicity, i.e. the ability to be associated with the pathogenesis of various diseases. The goal of this article is to present the most recent advances in understanding of this protein and its aggregation and to show that the remarkable structural, functional, and dysfunctional multifaceted nature of &alpha;-synuclein can be understood using the proteoform concept.">
            <meta name="citation_keywords" content="&alpha;-synuclein, aggregation, synucleinopathies, multifunctionality">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Vladimir N. Uversky">
            <meta name="citation_author_institution" content="Department of Molecular Medicine and USF Health Byrd Alzheimer&#700;s Research Institute, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd. MDC07, Tampa, FL, 33620, USA">
            <meta name="citation_author_institution" content="Laboratory of New Methods in Biology, Institute for Biological Instrumentation, Russian Academy of Sciences, 7 Institutskaya St., 142290 Pushchino, Moscow Region, Russian Federation">
            <meta name="citation_author_institution" content="Laboratory of Structural Dynamics, Stability and Folding Of Proteins, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Av., 194064 St. Petersburg, Russian Federation">
            <meta name="citation_publication_date" content="2017/04/20">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="525">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10536.1">
            <meta name="citation_firstpage" content="525">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-525/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-525.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11354 /> <input type=hidden id=articleId name=articleId value=10536 /> <input type=hidden id=xmlUrl value="/articles/6-525/v1/xml"/> <input type=hidden id=xmlFileName value="-6-525-v1.xml"> <input type=hidden id=article_uuid value=d6568425-7311-4634-8f5c-e3df37bf807f /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform prism"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10536.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10536.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-525"
  },
  "headline": "Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform...",
  "datePublished": "2017-04-20T14:35:36",
  "dateModified": "2017-04-20T14:35:36",
  "author": [
    {
      "@type": "Person",
      "name": "Vladimir N. Uversky"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Despite attracting the close attention of multiple researchers for the past 25 years, &alpha;-synuclein continues to be an enigma, hiding sacred truth related to its structure, function, and dysfunction, concealing mechanisms of its pathological spread within the affected brain during disease progression, and, above all, covering up the molecular mechanisms of its multipathogenicity, i.e. the ability to be associated with the pathogenesis of various diseases. The goal of this article is to present the most recent advances in understanding of this protein and its aggregation and to show that the remarkable structural, functional, and dysfunctional multifaceted nature of &alpha;-synuclein can be understood using the proteoform concept."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-525",
            "name": "Looking at the recent advances in understanding Î±-synuclein and its..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Looking at the recent advances in understanding Î±-synuclein and its... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11354 data-id=10536 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10536.1" data-recommended="" data-doi="10.12688/f1000research.10536.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-525/v1/pdf?article_uuid=d6568425-7311-4634-8f5c-e3df37bf807f" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10536-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10536-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10536-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Uversky VN. Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform prism [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):525 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10536.1" target=_blank>https://doi.org/10.12688/f1000research.10536.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10536-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10536 id=track-article-signin-10536 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10536?target=/articles/6-525">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11354 /> <input name=articleId type=hidden value=10536 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform prism</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:vuversky@health.usf.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Vladimir N. Uversky</span></a><a href="https://orcid.org/0000-0002-4037-5857" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4037-5857</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:vuversky@health.usf.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Vladimir N. Uversky</span></a><a href="http://orcid.org/0000-0002-4037-5857" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4037-5857</div><sup>1-3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 Apr 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10536.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Molecular Medicine and USF Health Byrd Alzheimer&#700;s Research Institute, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd. MDC07, Tampa, FL, 33620, USA<br/> <sup>2</sup> Laboratory of New Methods in Biology, Institute for Biological Instrumentation, Russian Academy of Sciences, 7 Institutskaya St., 142290 Pushchino, Moscow Region, Russian Federation<br/> <sup>3</sup> Laboratory of Structural Dynamics, Stability and Folding Of Proteins, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Av., 194064 St. Petersburg, Russian Federation<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20882-20585></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20883-20584></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Despite attracting the close attention of multiple researchers for the past 25 years, Î±-synuclein continues to be an enigma, hiding sacred truth related to its structure, function, and dysfunction, concealing mechanisms of its pathological spread within the affected brain during disease progression, and, above all, covering up the molecular mechanisms of its multipathogenicity, i.e. the ability to be associated with the pathogenesis of various diseases. The goal of this article is to present the most recent advances in understanding of this protein and its aggregation and to show that the remarkable structural, functional, and dysfunctional multifaceted nature of Î±-synuclein can be understood using the proteoform concept. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Î±-synuclein, aggregation, synucleinopathies, multifunctionality </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Vladimir N. Uversky (<a href="mailto:vuversky@health.usf.edu">vuversky@health.usf.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Vladimir N. Uversky </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; Â© 2017 Uversky VN. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Uversky VN. Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform prism [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):525 (<a href="https://doi.org/10.12688/f1000research.10536.1" target=_blank>https://doi.org/10.12688/f1000research.10536.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 Apr 2017, <b>6</b>(F1000 Faculty Rev):525 (<a href="https://doi.org/10.12688/f1000research.10536.1" target=_blank>https://doi.org/10.12688/f1000research.10536.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 Apr 2017, <b>6</b>(F1000 Faculty Rev):525 (<a href="https://doi.org/10.12688/f1000research.10536.1" target=_blank>https://doi.org/10.12688/f1000research.10536.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e158>Introduction</h2><p class="" id=d29942e161>Î±-synuclein is a small, highly abundant, and highly conserved presynaptic protein with intimate links to many neurodegenerative diseases and is one of the more intensively studied human proteins. In fact, since its discovery in 1991<sup><a href="#ref-1">1</a></sup>, followed by the demonstration of its natively unfolded nature<sup><a href="#ref-2">2</a></sup>, and especially after finding in 1997 a potential relationship between Î±-synuclein aggregation and the pathology of Parkinsonâs disease (PD)<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>, this protein has attracted the close attention of many researchers specializing in various scientific areas. According to the Web of Science database, as of 17 February 2017, there were 15,367 publications about this protein, reflecting collective efforts of 37,066 researchers affiliated with 6,326 organizations from 93 countries/territories, and more than 3,140 papers were published on Î±-synuclein during the past 2 years alone. <a href="#f1">Figure 1</a> represents a more detailed view of these Web of Science data by showing the cumulative number of publications for the past 26 years and the annual number of publications dedicated to this protein.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11354/e1a14e07-41da-4b56-a3bb-45c6ee341643_figure1.gif"><img alt="e1a14e07-41da-4b56-a3bb-45c6ee341643_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11354/e1a14e07-41da-4b56-a3bb-45c6ee341643_figure1.gif"></a><div class=caption><h3>Figure 1. A time course of the development of interest in Î±-synuclein-related research.</h3><p id=d29942e192>Web of Science data related to the publications dedicated to Î±-synuclein: the cumulative number of publications for the past 26 years (pink area plot) and the annual number of publications dedicated to this protein (cyan bars).</p></div></div><p class="" id=d29942e199>Despite immense efforts, this 25-year-old enigmatic protein continues to keep multiple secrets related to its structure, function, dysfunction, multipathogenicity, and pathology transmission. The aforementioned considerations constitute a perfect stage for an important question related to Î±-synuclein: what is so special about this protein that makes it a multipathogenicity carrier? The goal of this article is to shed some light on Î±-synuclein-related mysteries by presenting the most recent advances in our understanding of this protein and its aggregation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e205>Multipathogenicity angle</h2><p class="" id=d29942e208>To better understand why researchers continue to study this protein, letâs consider what multipathogenicity means for Î±-synuclein. Although originally considered a potential cause of PD (where aggregated Î±-synuclein is present in the form of intracellular inclusions, Lewy bodies [LBs] and Lewy neurites [LNs]<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>), this protein is known to be involved in the pathogenesis of a diverse group of neurodegenerative diseases collectively known as synucleinopathies. Some of these maladies include Alzheimerâs disease (AD), neurodegeneration with brain iron accumulation type 1, pure autonomic failure, Downâs syndrome, amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam, multiple system atrophy (MSA), and several LB disorders (that, in fact, might represent a clinical continuum<sup><a href="#ref-7">7</a></sup>), such as sporadic and familial PD, dementia with LBs (DLB), diffuse LB disease, the LB variant of AD, and PD dementia<sup><a href="#ref-4">4</a>,<a href="#ref-8">8</a>â<a href="#ref-15">15</a></sup>. These (and potentially many other) neurodegenerative diseases can be considered Î±-synuclein-related brain amyloidoses, since all of them are characterized by the presence of common pathological intracellular inclusions containing Î±-synuclein in selectively vulnerable neurons and glia and since the onset and progression of their clinical symptoms, as well as the degeneration of affected brain regions, are linked to the formation of abnormal filamentous aggregates containing Î±-synuclein<sup><a href="#ref-9">9</a>,<a href="#ref-15">15</a>â<a href="#ref-21">21</a></sup>. Importantly, accumulated evidence indicates that Î±-synuclein-based aggregation and deposition of LBs can affect multiple areas of the peripheral and central nervous systems, such as the dorsal raphe nucleus, dorsal nucleus of the vagus nerve, hypothalamic nuclei, intermediolateral nucleus, locus coeruleus, nucleus basalis of Meynert, and substantia nigra<sup><a href="#ref-22">22</a></sup>, whereas LNs can be found in the basal ganglia, cerebral cortex, dorsal nucleus of the vagus nerve, and sympathetic ganglia as well as in the intramural autonomic ganglia of the gastrointestinal tract<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>. In line with these earlier observations, a recent study of the inclusion pathologies in PD and DLB confirmed the abundant presence of LBs and LNs in the dorsal motor vagal and solitary nuclei, locus coeruleus, parabrachial nuclei, pedunculopontine and raphe nuclei, periaqueductal gray, prepositus hypoglossal, substantia nigra, reticular formation, and ventral tegmental area and demonstrated the presence of LN in brainstem fiber tracts and the existence of LBs and LNs in cranial nerve, premotor oculomotor, precerebellar, and vestibular brainstem nuclei<sup><a href="#ref-25">25</a></sup>. This study also supported an important notion that Î±-synuclein deposition-related pathological processes can spread and do so transneuronally along anatomical pathways<sup><a href="#ref-25">25</a></sup>. Recently, application of the Î±-synuclein proximity ligation assay revealed the presence in the post-mortem brain tissue from PD patients of previously unrecognized pathology in the form of extensive diffuse deposition of Î±-synuclein oligomers that were often localized, in the absence of LBs, to neuroanatomical regions mildly affected in PD<sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d29942e266>Obviously, although the diversity of synucleinopathies and related symptoms potentially can be attributed to the complexity of the organization of brain and nervous system (different motor and non-motor symptoms are the manifestation of the malfunction of different brain and nervous system regions), this complexity, in general, cannot be used to explain the cause of the multifaceted, Î±-synuclein-related pathology at the molecular level. In fact, since Î±-synuclein is highly expressed throughout the brain, accounting for as much as 1% of the total protein in soluble cytosolic brain fractions<sup><a href="#ref-27">27</a></sup>, and since any given synucleinopathy possesses unique spatiotemporal characteristics (happens at a specific time due to the malfunction of a specific brain region), some other factors, likely related to Î±-synuclein and its interaction with the environment (such as mutations in the <i>SYNC</i> gene, presence of alternatively spliced isoforms, post-translational modifications (PTMs), toxic insult, oxidative stress, presence of dopamine, metal ions, specific binding partners, etc.), should be taken into account.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e279>Connection of synucleinopathies to other diseases angle</h2><p class="" id=d29942e282>Recent studies provided further support for an interesting molecular link between the synucleinopathies and other neurodegenerative diseases by demonstrating the ability of Î±-synuclein to interact with and regulate proteins specific to several degenerative maladies. For example, it was shown that Î±-synuclein can interact and co-aggregate with mutant huntingtin, a protein related to Huntington's disease<sup><a href="#ref-28">28</a></sup>, and with tau protein, the aggregation of which is associated with various tauopathies, including AD<sup><a href="#ref-29">29</a></sup>. A cooperation of Î±-synuclein with Î²-amyloid (AÎ²) was shown to block SNARE-dependent vesicle fusion<sup><a href="#ref-30">30</a></sup>, whereas interaction with AÎ² led to the inhibition of AÎ² deposition and reduced plaque formation<sup><a href="#ref-31">31</a></sup>. Finally, Î±-synuclein was also shown to engage in interaction with autophagy/beclin1 regulator 1, a protein related to MSA pathogenesis, and this binding was dramatically enhanced by the Î±-synuclein phosphorylation at serine 129<sup><a href="#ref-32">32</a></sup>. Note that the aforementioned interactions of Î±-synuclein with the proteins associated with other neurodegenerative diseases can be grouped into two classes â interactions leading to the co-aggregation of Î±-synuclein with said proteins and interactions leading to the modulation of functionality of proteins targeted by Î±-synuclein.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e308>Multifunctionality angle</h2><p class="" id=d29942e311>Many papers in the field start with an introductory sentence stating that Î±-synuclein is a small, highly conserved presynaptic protein with unknown function. This statement is a bit odd, taking into account all the efforts of numerous researchers working on Î±-synuclein. In fact, according to the PubMed database (as of 16 December 2016), there were more than 7,150 papers mentioning synuclein function, many of those papers were dedicated to the detailed investigation of what this protein can do, and, as a result, many potential functions were ascribed to Î±-synuclein. The explanation of this contradiction (many functions are described, but function is unknown) is in the logistics of the classical structural biology relying on the influential âone gene â one enzyme â one functionâ hypothesis, according to which each gene encodes a single protein that has a unique biological function and is responsible for a single step in a metabolic pathway<sup><a href="#ref-33">33</a></sup>. In line with this hypothesis, distortion of normal protein function (in the form of loss of a normal function or gain of a pathological function) might represent the molecular basis of a proteinopathy.</p><p class="" id=d29942e318>However, since Î±-synuclein was shown to have not one but many functions (see below), this immediately brought significant uneasiness to functional data interpretation, leading to the logical conclusion that the observed multifunctionality indicates the lack of a unique function and, therefore, could be unreal. Although, from the viewpoint of the âone protein â one functionâ model, these observations provide grounds for the âprotein with unknown functionâ epithet, an alternative (and much more intriguing and lucrative) hypothesis stating that Î±-synuclein is indeed a multifunctional protein, which can, in fact, do everything ascribed to it (and, probably, much more than that). In this case, problems with different Î±-synuclein-based functions might be directly or indirectly related to the pathogenesis of different synucleinopathies. In other words, a spectrum of functions can cause a spectrum of dysfunctions that might lead to a spectrum of diseases.</p><p class="" id=d29942e321>Early work in this direction showed that functions of Î±-synuclein can range from fatty acid binding<sup><a href="#ref-34">34</a></sup> to interaction with plasma membranes and formation of membrane channels or modification of their activity<sup><a href="#ref-35">35</a></sup>, association with mitochondria causing mitochondrial dysfunction<sup><a href="#ref-35">35</a></sup>, metal binding<sup><a href="#ref-36">36</a>â<a href="#ref-39">39</a></sup>, interaction with pesticides and herbicides<sup><a href="#ref-40">40</a>â<a href="#ref-42">42</a></sup>, synaptic vesicle release and trafficking<sup><a href="#ref-34">34</a></sup>, positive and negative regulation of neurotransmitter release<sup><a href="#ref-43">43</a></sup>, regulation of certain enzymes and transporters<sup><a href="#ref-34">34</a></sup>, control of neuronal survival<sup><a href="#ref-34">34</a></sup>, regulation of the neuronal apoptotic response<sup><a href="#ref-44">44</a></sup> and protection of neurons from various apoptotic stimuli<sup><a href="#ref-44">44</a></sup>, and promiscuous interaction with hundreds of unrelated proteins and other binding partners<sup><a href="#ref-34">34</a>,<a href="#ref-45">45</a>â<a href="#ref-47">47</a></sup>. In the past 2 years, the phenomenon of Î±-synuclein multifunctionality was further confirmed and elaborated by adding a long list of new functions. Note that the inventory below is far from being exhaustive, since over 1,100 articles dedicated to synuclein function were published during the last 2 years, and, therefore, it is physically impossible to cover all new developments in this commentary owing to the space restrictions.</p><div class=section><a name=d29942e386 class=n-a></a><h3 class=section-title>Knockout studies of the synuclein functionality</h3><p class="" id=d29942e391>Knockout experiments, where the target gene is made inoperative, represent a useful approach for the evaluation of the global biological role of a query protein. Earlier studies showed that although Î±-synuclein-null mice were viable, fertile, and characterized by intact brain architecture, they possessed altered dopamine release and displayed a reduction in striatal dopamine and attenuated dopamine-dependent locomotor response<sup><a href="#ref-48">48</a></sup>. Furthermore, Î±-synuclein-null mice were characterized by a selective deficiency of undocked vesicles without affecting docked vesicles in hippocampal synapses<sup><a href="#ref-49">49</a></sup>, showed abnormal compartmentalization of norepinephrine in dentate gyrus<sup><a href="#ref-50">50</a></sup>, possessed greatly increased rates of operant behavior during intracranial self-stimulation<sup><a href="#ref-51">51</a></sup>, and showed an earlier onset of symptoms of experimental autoimmune encephalomyelitis<sup><a href="#ref-52">52</a></sup> but were resistant to the Parkinsonian neurotoxin MPTP that inhibits mitochondrial complex I<sup><a href="#ref-53">53</a></sup>. This MPTP resistance was also present in the Î³-synuclein and double Î±-synuclein/Î³-synuclein-null mutant animals<sup><a href="#ref-54">54</a></sup>, and Î±-synuclein-null mice were shown to have an attenuated loss of striatal dopamine caused by prolonged chronic MPTP administration<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d29942e427>Multiple studies of the Î±-synuclein-knockout models suggested that this protein plays a role in lipid metabolism. In fact, Î±-synuclein-null animals were characterized by decreased brain palmitate uptake and altered palmitate metabolism<sup><a href="#ref-56">56</a></sup>, showed increased incorporation and turnover of the docosahexaenoic acid in brain phospholipids<sup><a href="#ref-57">57</a></sup>, possessed reduced arachidonate turnover in brain phospholipids<sup><a href="#ref-58">58</a></sup>, and showed increased mass of brain neutral lipids<sup><a href="#ref-59">59</a></sup>.</p></div><div class=section><a name=d29942e448 class=n-a></a><h3 class=section-title>Binding promiscuity</h3><p class="" id=d29942e453>Among biological activities recently ascribed to Î±-synuclein is a numerous set of examples providing solid support for its reputation as a promiscuous binder. In fact, multiple new examples were reported showing that this protein is engaged in interaction with the multifunctional co-chaperone Bcl-2-associated athanogene-1<sup><a href="#ref-60">60</a></sup>, prolyl oligopeptidase leading to enhanced Î±-synuclein dimerization<sup><a href="#ref-61">61</a></sup>, various synaptosomal proteins<sup><a href="#ref-62">62</a></sup>, mitochondria-associated membranes<sup><a href="#ref-63">63</a></sup>, molecular chaperone Munc18-1, which is a key component of the exocytic machinery that controls the release of neurotransmitters<sup><a href="#ref-64">64</a></sup>, the neuronal phosphoprotein synapsin III<sup><a href="#ref-65">65</a></sup>, voltage-dependent anion channel<sup><a href="#ref-66">66</a></sup>, a suicide inhibitor of monoamine oxidases, rasagiline<sup><a href="#ref-67">67</a></sup>, and the aldehyde of serotonin, 5-hydroxyindoleacetaldehyde<sup><a href="#ref-68">68</a></sup>.</p></div><div class=section><a name=d29942e494 class=n-a></a><h3 class=section-title>Control of cellular processes</h3><p class="" id=d29942e499>Furthermore, Î±-synuclein has been linked to several cellular processes, such as activation of microglia<sup><a href="#ref-69">69</a></sup>, involvement in the regulation of autophagy<sup><a href="#ref-70">70</a>,<a href="#ref-71">71</a></sup>, initiation of innate and adaptive immune responses<sup><a href="#ref-72">72</a></sup>, membrane remodeling<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>, regulation of synaptic vesicle size<sup><a href="#ref-75">75</a></sup>, contribution to axonal transport impairment<sup><a href="#ref-76">76</a></sup>, stress-induced mitochondrial morphological remodeling (in cooperation with parkin and PINK1)<sup><a href="#ref-77">77</a></sup>, alteration of endoplasmic reticulumâmitochondrial communication<sup><a href="#ref-78">78</a></sup>, promotion of microtubule nucleation and enhancement of microtubule growth rate via interaction with microtubules and tubulin Î±<sub>2</sub>Î²<sub>2</sub> tetramer<sup><a href="#ref-79">79</a></sup>, and inhibition of signaling related to the ATF6 pathway, which is a protective branch of the unfolded protein response<sup><a href="#ref-80">80</a></sup>, and even serving as a brain antimicrobial peptide that exhibits noticeable antibacterial activity against <i>Escherichia coli</i> and <i>Staphylococcus aureus</i><sup><a href="#ref-81">81</a></sup>.</p></div><div class=section><a name=d29942e566 class=n-a></a><h3 class=section-title>Î±-synuclein radicals</h3><p class="" id=d29942e571>Recently, Kumar <i>et al</i>. exploited an intriguing possibility that the formation of proteinaceous radicals might contribute to PD pathogenesis<sup><a href="#ref-82">82</a></sup>. Using the highly sensitive immuno-spin trapping technique, the authors showed that in the midbrains of maneb- and paraquat-co-exposed mice, the activation of NADPH oxidase and inducible nitric oxide synthase took place, eventually leading to the peroxynitrite-mediated formation of Î±-synuclein radicals in the dopaminergic neurons of exposed mice<sup><a href="#ref-82">82</a></sup>. Furthermore, the process of Î±-synuclein radical formation paralleled death dopaminergic neurons in the midbrains of maneb- and paraquat-co-exposed mice, indicating that there is an intricate link between protein radicals and disease progression<sup><a href="#ref-82">82</a></sup>.</p></div><div class=section><a name=d29942e590 class=n-a></a><h3 class=section-title>Regulation of various proteins</h3><p class="" id=d29942e595>Î±-synuclein was also shown to regulate complexin-1 and midbrain-specific factor forkhead box P1 expression<sup><a href="#ref-83">83</a></sup>, enhance histone H3 lysine-9 (H3K9) dimethylation and promote H3K9me2-dependent transcriptional responses<sup><a href="#ref-84">84</a></sup>, protect the functions of Hsp90 clients, such as Akt and mTOR, when the activity of Hsp90 is blocked<sup><a href="#ref-85">85</a></sup>, stimulate protein phosphatase-2A (PP2A) activity and regulate tyrosine hydroxylase phosphorylation via the control of PP2A methylation<sup><a href="#ref-86">86</a></sup>, modulate the trafficking and function of glutamate N-methyl-d-aspartate receptor<sup><a href="#ref-87">87</a></sup>, and promote Notch1 intracellular domain degradation via interaction with the ubiquitin E3 ligase Fbw7<sup><a href="#ref-88">88</a></sup>.</p></div><div class=section><a name=d29942e624 class=n-a></a><h3 class=section-title>Î±-synuclein in the family circle</h3><p class="" id=d29942e629>Synucleins constitute a family of closely related presynaptic proteins encoded by three distinct genes and are found only in vertebrates<sup><a href="#ref-89">89</a></sup>. In addition to Î±-synuclein, which is also known as the non-amyloid-Î² component (NAC) precursor protein or synelfin<sup><a href="#ref-90">90</a>â<a href="#ref-92">92</a></sup>, this family includes Î²-synuclein (phosphoneuroprotein 14 or PNP14)<sup><a href="#ref-92">92</a>â<a href="#ref-94">94</a></sup>, and Î³-synuclein (breast cancer-specific gene 1 [<i>BCSG1</i>] or persyn)<sup><a href="#ref-95">95</a>â<a href="#ref-98">98</a></sup>. There is 78% identity between human Î±- and Î²-synucleins, with the major difference between the two being the lack of the significant part of the NAC region<sup><a href="#ref-13">13</a>,<a href="#ref-99">99</a></sup>. Human Î³-synuclein shares 60% sequence similarity with Î±-synuclein and lacks the tyrosine-rich C-terminal tail that represents a signature of Î±- and Î²-synucleins<sup><a href="#ref-13">13</a>,<a href="#ref-99">99</a></sup>. Importantly, in addition to the traditional Î±-synuclein-containing pathological inclusions, the development of several synucleinopathies is accompanied by the appearance of Î±-, Î²-, and Î³-synuclein-positive vesicular-like lesions at the presynaptic axon terminals in the hippocampal dentate, hilar, and CA2/3 regions<sup><a href="#ref-100">100</a></sup>.</p><p class="" id=d29942e679>Structurally, all members of the synuclein family are intrinsically disordered at physiological conditions but adopt comparable partially folded conformations at acidic pH or at high temperature<sup><a href="#ref-101">101</a></sup>. Both Î±- and Î³-synucleins can easily form fibrils under a variety of identical conditions<sup><a href="#ref-101">101</a></sup>, whereas Î²-synuclein fibrillation requires the presence of some metal ions (Zn<sup>2+</sup>, Pb<sup>2+</sup>, and Cu<sup>2+</sup>)<sup><a href="#ref-102">102</a></sup>.</p><p class="" id=d29942e704>Fibrillation of human Î±-synuclein can be inhibited by the addition of either Î²- or Î³-synuclein <i>in vitro</i><sup><a href="#ref-101">101</a></sup>, with Î²-synuclein being shown to inhibit Î±-synuclein aggregation in an animal model<sup><a href="#ref-103">103</a></sup>. NMR paramagnetic relaxation enhancement experiments revealed that Î²-synuclein forms transient heterodimers with Î±-synuclein that are characterized by high specificity and weak affinity<sup><a href="#ref-104">104</a></sup>. Recently, the competition of Î²-synuclein for binding sites at the surfaces of lipid vesicles and at the surfaces of Î±-synuclein fibrils was proposed as a molecular mechanism of the Î²-synuclein-driven inhibition of lipid-induced Î±-synuclein aggregation and secondary nucleation of Î±-synuclein fibrillation, respectively<sup><a href="#ref-105">105</a></sup>. In agreement with this inhibitory action of Î²-synuclein, some positive results of the use of Î²-synuclein as a means for reducing aggregated Î±-synuclein levels were obtained in preclinical studies<sup><a href="#ref-106">106</a></sup>.</p><p class="" id=d29942e729>Double-knockout of Î±- and Î²-synucleins in mice did not impair basic brain functions or survival, and no significant changes were detected in the ultrastructure of synuclein-deficient synapses, in synaptic plasticity, or in the pool size of synaptic vesicles<sup><a href="#ref-107">107</a></sup>. However, these double null animals were characterized by the decreased dopamine levels in their brains and showed selective changes in the levels of synaptic signaling proteins, such as complexins and 14-3-3 proteins<sup><a href="#ref-107">107</a></sup>. Recently, analysis of the triple Î±-synuclein/Î²-synuclein/Î³-synuclein-knockout mice revealed that these proteins have profound effects on the presynaptic architecture and serve as âimportant orchestrators of presynaptic terminal topographyâ, regulating presynapse size and organization of the pool of synaptic vesicles<sup><a href="#ref-108">108</a></sup>. A systematic analysis of the structural and functional features of the nigrostriatal system in mice with every possible combination of knockout members of the synuclein family revealed that although these proteins have noticeable functional redundancy, some functions are specific for a particular member and therefore the remaining synucleins cannot fully compensate for the deficiency of a lost family member<sup><a href="#ref-109">109</a></sup>. For example, Î²-synuclein was shown to be needed for the efficient maintenance of balance and coordination in aged animals, whereas the presence of Î±-synuclein is crucial for stabilization of the striatal dopamine level and cannot be compensated by other family members<sup><a href="#ref-109">109</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e756>Regulatability angle</h2><p class="" id=d29942e759>Also, a set of recent studies was dedicated to the analysis of various means of regulation of Î±-synuclein, its normal and pathological functions, and aggregation. It was shown that this protein can be regulated, at the expression level, by the microRNAs miR-34b and miR-34c<sup><a href="#ref-110">110</a></sup> as well as miR-19b, miR-29a, and miR-29c<sup><a href="#ref-111">111</a></sup>, by promoter methylation in the Î±-synuclein gene <i>SNCA</i><sup><a href="#ref-112">112</a></sup>, and by other means of epigenetic-mediated regulation<sup><a href="#ref-113">113</a></sup>. Aggregation of Î±-synuclein can be controlled by antibodies at substoichiometric concentrations (as low as 1:1000 antibody to protein ratio)<sup><a href="#ref-114">114</a></sup>. Different monoclonal anti-C-terminal antibodies were shown to differently interact with different forms of Î±-synuclein (monomeric or aggregated), with the antibodies with the strongest binding to aggregated protein also being the strongest inhibitors of Î±-synuclein fibrillation and membrane permeabilization<sup><a href="#ref-115">115</a></sup>. Aggregation of Î±-synuclein can be modulated via interaction with the moonlighting 14-3-3 proteins that act as ATP-independent anti-aggregation âholdasesâ<sup><a href="#ref-116">116</a></sup>, by caspase-1-mediated truncation<sup><a href="#ref-117">117</a></sup>, by the small secretory chaperone proSAAS<sup><a href="#ref-118">118</a></sup>, or by <i>Geum urbanum</i> extract<sup><a href="#ref-119">119</a></sup>. The aggregation, toxicity, levels, and secretion of Î±-synuclein were shown to be controlled by endocytic recycling pathway components, such as Rab8b, Rab11a, Rab13, and Slp5<sup><a href="#ref-120">120</a></sup>. Also, interaction with an anti-amyloidogenic agent, ginsenoside Rg1, was shown to inhibit the fibrillation and toxicity of Î±-synuclein and disaggregate preformed fibrils<sup><a href="#ref-121">121</a></sup>. The extracellular Î±-synuclein can be sorted in extracellular vesicles in a SUMOylation-dependent manner<sup><a href="#ref-122">122</a></sup>, whereas the extracellular release of this protein is controlled by the DnaJ/Hsc70 chaperone complexes<sup><a href="#ref-123">123</a></sup>. The nuclear accumulation and toxicity of Î±-synuclein can be regulated by a novel protein, TRIM28<sup><a href="#ref-124">124</a></sup>, that controls the fate specification of the neural cells<sup><a href="#ref-125">125</a></sup>, whereas loss of lysosomal Î²-glucocerebrosidase activity promotes global intracellular accumulation and toxicity of Î±-synuclein<sup><a href="#ref-126">126</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e842>Structural polymorphism angle</h2><div class=section><a name=d29942e845 class=n-a></a><h3 class=section-title>Protein-chameleon</h3><p class="" id=d29942e850>The immense multifunctionality and related multipathogenicity of Î±-synuclein suggest that this protein should have a highly amenable structure to be able to do everything ascribed to it. In agreement with this hypothesis, it was recognized early on that Î±-synuclein is a typical intrinsically disordered protein (IDP) that does not have a stably folded structure under physiological conditions<sup><a href="#ref-2">2</a>,<a href="#ref-127">127</a></sup>. Furthermore, Î±-synuclein can serve as an illustrative example of the protein-chameleon concept<sup><a href="#ref-128">128</a></sup>, where protein has a highly pliable structure that is extremely sensitive to the environmental conditions. Such a protein is able to morph under the action of numerous factors. As a result, Î±-synuclein may "stay substantially unfolded, or adopt an amyloidogenic partially folded conformation, or fold into Î±-helical or Î²-structural species, both monomeric and oligomeric. Furthermore, it might form several morphologically different types of aggregates, including oligomers (spheres or doughnuts), amorphous aggregates, and or amyloid-like fibrils"<sup><a href="#ref-128">128</a></sup>.</p><p class="" id=d29942e868>The intrinsically disordered nature of Î±-synuclein is not only a property of the purified protein <i>in vitro</i> but also preserved <i>in vivo</i>, as shown by the analysis of this protein endogenously expressed in the central nervous system, erythrocytes, and mammalian cell lines using native and denaturing gel electrophoresis techniques, size-exclusion chromatography, and an oligomer-specific ELISA<sup><a href="#ref-129">129</a></sup>. Compelling support for this idea was also provided by the results of the in-cell NMR analysis of human protein expressed in bacteria<sup><a href="#ref-130">130</a></sup>. Very recently, further evidence of the preservation of the disordered nature of monomeric Î±-synuclein under physiological cell conditions was given by the application of the in-cell NMR and electron paramagnetic resonance spectroscopy to derive the atomic-level information on the structure and dynamics of Î±-synuclein in different mammalian non-neuronal and neuronal cells<sup><a href="#ref-131">131</a></sup>. Based on the molecular dynamics studies, it has also been concluded that a disordered monomer represents the dominant state within the structural ensemble of Î±-synuclein<sup><a href="#ref-132">132</a></sup>.</p></div><div class=section><a name=d29942e895 class=n-a></a><h3 class=section-title>Residual structure</h3><p class="" id=d29942e900>It was pointed out that although Î±-synuclein behaves as a highly disordered protein, the solution conformation of this protein is not a random coil but contains some residual structure<sup><a href="#ref-127">127</a>,<a href="#ref-133">133</a></sup>. This residual structure is extremely sensitive to various environmental factors<sup><a href="#ref-134">134</a></sup>. For example, based on the in-cell NMR analysis, it was recently concluded that the conformations of Î±-synuclein in the cellular environment are more compact than those of the isolated protein <i>in vitro</i><sup><a href="#ref-131">131</a></sup>. These more compact <i>in vivo</i> conformations provide efficient shielding of the residues of the aggregation-prone NAC region, thereby counteracting spontaneous aggregation<sup><a href="#ref-131">131</a></sup> and supporting the âfunctional misfoldingâ hypothesis, according to which a polypeptide chain of an IDP can spontaneously misfold âto sequester the preformed elements inside the non-interactive or less-interactive cage, therefore preventing these elements from the unnecessary and unwanted interactions with non-native binding partnersâ<sup><a href="#ref-135">135</a></sup>.</p></div><div class=section><a name=d29942e933 class=n-a></a><h3 class=section-title>Effects of post-translational modifications</h3><p class="" id=d29942e938>Similar to many other IDPs, Î±-synuclein is subject to numerous PTMs, such as phosphorylation, ubiquitination, SUMOylation, O-GlcNAcylation, N-terminal acetylation, nitrosylation, and truncation, among which phosphorylation, truncation, and ubiquitination are believed to be the major disease-associated PTMs<sup><a href="#ref-136">136</a>,<a href="#ref-137">137</a></sup>. Since Î±-synuclein might have multiple PTMs affecting different residues, and since multiple sites can be subjected to a given PTM (e.g. phosphorylation might occur at S87, S129, or Y125, whereas K12, K21, or K23 can be subjected to ubiquitination), this protein is likely to be highly heterogeneous in its native state. This PTM-driven heterogeneity creates an important problem related to understanding the role of individual PTMs in the structural properties, normal function, misfolding, aggregation, and dysfunction of Î±-synuclein. Besides the identification of the enzymes involved in regulating these PTMs, a solution to this problem requires the preparation of site-specifically modified proteins. A breakthrough in this direction was achieved in Lashuelâs group, who elaborated a set of enzymatic, synthetic, and semisynthetic strategies for the site-specific and tightly controlled introduction of PTMs at single or multiple sites<sup><a href="#ref-138">138</a>â<a href="#ref-142">142</a></sup>. These approaches pave the way for generating pure and homogenously modified samples of Î±-synuclein.</p></div><div class=section><a name=d29942e956 class=n-a></a><h3 class=section-title>Effects of familial PD mutations</h3><p class="" id=d29942e961>Among the important factors responsible for the modulation of Î±-synucleinâs residual structure are familial PD mutations. In addition to âtraditionalâ PD mutations (such as A53T<sup><a href="#ref-3">3</a></sup>, A30P<sup><a href="#ref-143">143</a></sup>, and E46K<sup><a href="#ref-144">144</a></sup>) that have been known to the scientific community for a relatively long time, several ânewâ disease-associated mutations in Î±-synuclein (H50Q<sup><a href="#ref-145">145</a>,<a href="#ref-146">146</a></sup>, G51D<sup><a href="#ref-147">147</a>,<a href="#ref-148">148</a></sup>, and A53E<sup><a href="#ref-149">149</a></sup>) were discovered over the past 3 years. These mutations were shown to differently modulate Î±-synuclein functions and aggregation propensity. For example, the formation of non-fibrillar aggregate (such as oligomers or protofibrils) and not fibrils was accelerated by the A30P mutation<sup><a href="#ref-150">150</a>,<a href="#ref-151">151</a></sup>. Two other âtraditionalâ PD mutants, A53T and E46K, were both shown to be characterized by accelerated fibrillation<sup><a href="#ref-150">150</a>,<a href="#ref-152">152</a>â<a href="#ref-154">154</a></sup>. Similarly, aggregation and fibrillation of the H50Q mutant were dramatically accelerated<sup><a href="#ref-155">155</a></sup>. On the other hand, significant reduction in Î±-synuclein oligomerization and fibrillation was induced by the G51D and A53E mutations, with the G51D mutant shown to form amorphous aggregates<sup><a href="#ref-148">148</a>,<a href="#ref-156">156</a></sup>, and with the A53E mutant being able to eventually form very thin amyloid fibrils<sup><a href="#ref-156">156</a>â<a href="#ref-158">158</a></sup>.</p><p class="" id=d29942e1030>It is known that although mutations can modulate the aggregation propensity of Î±-synuclein, the global structure of this IDP is rather insensitive to mutations<sup><a href="#ref-150">150</a>,<a href="#ref-153">153</a>,<a href="#ref-157">157</a>,<a href="#ref-159">159</a>â<a href="#ref-163">163</a></sup>. Furthermore, based on the results of the extensive molecular dynamics simulations in aqueous solution, it has been concluded that fibril structure was not affected by PD-related mutations (A30P, E46K, H50Q, G51D, A53E, and A53T), but the relative stabilities of fibrillar structures and their conformational preferences were altered by mutations<sup><a href="#ref-164">164</a></sup>. However, the dynamics and residual structure present in the conformational ensembles of monomeric Î±-synuclein were clearly affected by the familial PD mutations<sup><a href="#ref-150">150</a>,<a href="#ref-153">153</a>,<a href="#ref-157">157</a>,<a href="#ref-159">159</a>â<a href="#ref-163">163</a></sup>. For example, by strategic placing of tryptophan residues, the effect of three PD mutations (A53T, E46K, and A30P) on the site-specific structural dynamics of this protein was analyzed<sup><a href="#ref-165">165</a></sup>. This analysis showed that mutations affected local conformational flexibility, microenvironment, and solvent exposure<sup><a href="#ref-165">165</a></sup>. Analysis of the effects of various mutations on the dynamics of the Î±-synuclein conformational ensemble revealed that the intramolecular diffusion of this protein is differently affected by aggregation-promoting and aggregation-inhibiting mutations, being correspondingly either drastically slowed down or accelerated in comparison with that of the wild-type protein<sup><a href="#ref-166">166</a></sup>. To address the role of tyrosine residues on early stages of Î±-synuclein aggregation and the effects of these residues on protein dynamics, three modeled Tyr mutants (Y39A, Y133A, and Y125A/Y133A/Y136A) were subjected to all-atom molecular dynamics simulation<sup><a href="#ref-167">167</a></sup>. This analysis revealed that the residue Tyr133 plays an important role in driving intramolecular interactions between the hydrophobic residues in the N- and C-terminal regions and is crucial for the fibrillation process<sup><a href="#ref-167">167</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e1094>Polymorphism of aggregated forms of Î±-synuclein angle</h2><p class="" id=d29942e1097>Not only is monomeric Î±-synuclein characterized by structural polymorphism but also its oligomeric and insoluble aggregated forms are polymorphic at both structural and functional levels. For example, application of the cryo-electron microscopy image reconstruction technique revealed that oligomers that are kinetically trapped during Î±-synuclein fibril formation are characterized by different sizes, Î²-sheet contents, and levels of exposed hydrophobicity<sup><a href="#ref-168">168</a></sup>. Also, two morphologically different oligomeric Î±-synuclein forms were found in human post-mortem PD brain tissue<sup><a href="#ref-169">169</a></sup>. The presence of two different types of oligomeric species formed by the wild-type Î±-synuclein and its familial PD-related mutants A30P, E46K, and A53T was described using hydrogen/deuterium exchange monitored by mass spectrometry<sup><a href="#ref-170">170</a></sup>. Although generated at specific conditions, oligomers of the wild-type Î±-synuclein and its familial PD-related mutants A30P, A53T, E46K, H50Q, and G51D have similar global structures and are composed of a similar number of monomers, but they interact differently with biological membranes<sup><a href="#ref-171">171</a></sup>.</p><p class="" id=d29942e1116>Several recent observations are in line with the idea that oligomeric/fibrillar forms of Î±-synuclein might be functionally different, indicating the presence of a functional polymorphism among the aggregated polymorphs. For example, it was found that fibrillar Î±-synuclein can trigger inflammatory responses, whereas oligomeric forms of this protein were unable to initiate these cascades<sup><a href="#ref-172">172</a></sup>. Although both oligomeric and fibrillar forms of Î±-synuclein are able to generate free radicals, only the oligomeric protein can reduce endogenous glutathione and cause subsequent neuronal toxicity<sup><a href="#ref-173">173</a></sup>. Also, microtubule assembly was shown to be efficiently inhibited by fibrillar Î±-synuclein, and this fibril-mediated inhibitory effect was greater than that of the oligomeric species (protofibrils)<sup><a href="#ref-174">174</a></sup>.</p><p class="" id=d29942e1131>Slight changes in the environmental conditions during the fibrillation process were shown to cause the formation of morphologically different amyloid fibrils with distinctive molecular characteristics that can be inherited by the next generation of fibrils through self-propagation<sup><a href="#ref-175">175</a></sup>. Under specific conditions, pure forms of structurally different fibrillar polymorphs of Î±-synuclein were obtained and characterized structurally and functionally<sup><a href="#ref-176">176</a></sup>. In addition to different morphologies, these polymorphs were characterized by different structures, different levels of toxicity, different <i>in vivo</i> and <i>in vitro</i> seeding and propagation properties<sup><a href="#ref-176">176</a></sup>, different molecular arrangement in the unit cell, and distinct dynamic features<sup><a href="#ref-177">177</a></sup>. Subsequent structural and physical characterization of several fibrillar polymorphs assembled from Î±-synuclein supported the notion that the same protein can assemble into a variety of large particles with fibrillar shapes, that fibrillar polymorphs are morphologically and nanomechanically different, and that exceptional structural and physical polymorphism is present within the fibrillar form of this protein<sup><a href="#ref-178">178</a></sup>. These findings provide mechanical foundation for better understanding of the nature of different Î±-synuclein strains<sup><a href="#ref-179">179</a></sup> that define the ability of the aggregated Î±-synuclein to be engaged in different neurodegenerative diseases<sup><a href="#ref-176">176</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e1172>Strains and transmission angle</h2><p class="" id=d29942e1175>It is important to note that the phenomenon of polymorphism of amyloid fibrils is not an exclusive property of Î±-synuclein but was described for other amyloidogenic proteins<sup><a href="#ref-180">180</a>,<a href="#ref-181">181</a></sup> and was linked to the phenomenon of strains originally found in mammalian prion protein<sup><a href="#ref-182">182</a>â<a href="#ref-185">185</a></sup> and now described for Î±-synuclein<sup><a href="#ref-179">179</a></sup>, yeast and fungal prions<sup><a href="#ref-186">186</a>â<a href="#ref-188">188</a></sup>, transthyretin<sup><a href="#ref-189">189</a></sup>, and insulin<sup><a href="#ref-190">190</a></sup> as well as AÎ²<sup><a href="#ref-191">191</a></sup> and tau protein<sup><a href="#ref-192">192</a></sup>. Strain phenomenon is related to the peculiarities of amyloid propagation and transmission, where different aggregated forms of a protein can cause the development of different pathologies. In relation to the subject of this article, the ability of Î±-synuclein to aggregate into distinct high-molecular-weight assemblies was proposed to be associated with the ability of this protein to cause different synucleinopathies<sup><a href="#ref-179">179</a></sup>. This idea is supported by the direct observation of the induction of different synucleinopathies after the administration of the different Î±-synuclein strains (oligomers, ribbons, and fibrils) by injection into rat brain<sup><a href="#ref-193">193</a></sup>.</p><p class="" id=d29942e1228>Another analogy of aggregated Î±-synuclein to prion protein is its âinfectivityâ, i.e. the ability to be efficiently transmitted between neurons, thereby supporting the pathological spread within the affected brain during disease progression (e.g. as described by Braak's staging criteria of PD<sup><a href="#ref-194">194</a>,<a href="#ref-195">195</a></sup>). Although original models describing interneuronal propagation suggested some passive release of aggregated Î±-synuclein from injured, degenerated, or dead neurons, a recent study showed that intact, relatively healthy neurons are engaged in efficient cell-to-cell passage of Î±-synuclein<sup><a href="#ref-196">196</a></sup>. It was also indicated that endosomal processing might serve as a point of convergence between the transcellular propagation of aggregated Î±-synuclein and the intracellular trafficking of this protein<sup><a href="#ref-197">197</a></sup>. A crucial role of high-affinity binding of preformed Î±-synuclein fibrils to the lymphocyte-activation gene 3 protein is for the initiation of endocytosis and transmission of aggregated Î±-synuclein, thereby propagating its toxicity and leading to the loss of dopamine neurons and the development of biochemical and behavioral deficits <i>in vivo</i><sup><a href="#ref-198">198</a></sup>. Importantly, it is not only exogenous fibrillar forms of Î±-synuclein that are able to promote cellular pathologies, since soluble amyloid oligomers that precede LB formation were also linked to the cell-to-cell transmission of Î±-synuclein pathology<sup><a href="#ref-199">199</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e1259>Concluding remarks: proteoforms to the rescue</h2><p class="" id=d29942e1262>The knowledge of the peculiar behavior of Î±-synuclein accumulated over the past two decades provides an illustration of an important notion that the complexity of a biological system is mostly determined by its proteome size and not by the genome size<sup><a href="#ref-200">200</a></sup>. In fact, the number of functionally different proteins found in eukaryotic organisms is substantially higher than the number of genes. The functional diversification of proteinaceous products of a gene is achieved by several means, including the allelic variations (i.e. single or multiple point mutations, indels, SNPs) at the DNA level, alternative splicing, and other pre-translational mechanisms affecting mRNA, complemented by a wide spectrum of various PTMs of a polypeptide chain. As a result of all of these events, a set of distinct protein molecules can be created from a single gene, giving rise to the proteoform concept<sup><a href="#ref-201">201</a></sup>. Recently, it was proposed that in addition to the aforementioned means that increase the chemical variability of a polypeptide chain, the proteinâs structural diversity can be further increased by some other mechanisms, such as intrinsic disorder and function<sup><a href="#ref-202">202</a></sup>. In this view, a correlation between protein structure and function is considered a âprotein structureâfunction continuumâ, where a given protein exists as a dynamic conformational ensemble containing multiple proteoforms (conformational/basic, inducible/modified, and functioning) characterized by diverse structural features and miscellaneous functions<sup><a href="#ref-202">202</a></sup>. In application to Î±-synuclein, the protein structureâfunction continuum idea is further enhanced by the presence of remarkable structural and functional variability of its self-aggregated forms. Therefore, due to its ability to oligomerize and aggregate, an intrinsically disordered Î±-synuclein is characterized by the enormously expanded set of proteoforms where each of the various monomeric, oligomeric, and insoluble species is further split into numerous conformational/basic, inducible/modified, and functioning proteoforms. In other words, as illustrated by <a href="#f2">Figure 2</a>, consideration of Î±-synuclein through the proteoform prism provides a logical explanation for its remarkable structural, functional, and dysfunctional multifaceted nature.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11354/e1a14e07-41da-4b56-a3bb-45c6ee341643_figure2.gif"><img alt="e1a14e07-41da-4b56-a3bb-45c6ee341643_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11354/e1a14e07-41da-4b56-a3bb-45c6ee341643_figure2.gif"></a><div class=caption><h3>Figure 2. Proteoform concept as a prism for looking at and understanding Î±-synuclein.</h3><p id=d29942e1294>Schematic representation of the proteoform concept using the analogy of a prism. Here, an âincident lightâ (Î±-synuclein gene, <i>SNCA</i>), while going through the proteoform âprismâ (a set of mechanisms put forward to generate different proteoforms), is âdiffractedâ, giving rise to a âspectrumâ of proteoforms (a set of chemically or structurally different forms of a protein) for conducting different functions.</p></div></div><p class="" id=d29942e1304>Outlined in this article, the proteoform-centric view of Î±-synuclein represents an important shift in understanding the biology and pathology of this protein. In fact, despite the enormous amount of effort expended by the scientific community to find a single most important physiological function of Î±-synuclein, there is no clear understanding of the unique biological role of this protein as of yet. However, as it follows from a great deal of the published work on Î±-synuclein, the applicability of the âone sequence â one structure â one functionâ paradigm to this protein is questionable. In other words, it seems that the search for a single physiological function of Î±-synuclein may be entirely misplaced, since the intrinsically disordered nature of the protein, which defines the structural polymorphism of the conformational ensemble of its monomeric form, bestows multifunctionality upon Î±-synuclein. Logical consequences of this structural heterogeneity and multifunctionality of a monomeric protein are the structural polymorphism of aggregated states and a âspectrum of dysfunctionsâ that define a range of diseases. Therefore, the enormous structural and functional complexity of Î±-synuclein has serious implications for future studies to understand the biology of this protein and for the development of future therapeutic strategies targeting Î±-synuclein.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d29942e1310>Abbreviations</h2><p class="" id=d29942e1313>AÎ², Î²-amyloid; AD, Alzheimerâs disease; DLB, dementia with Lewy bodies; H3K9, histone H3 lysine-9; IDP, intrinsically disordered protein; LB, Lewy body; LN, Lewy neurite; MSA, multiple system atrophy; NAC, non-amyloid-Î² component; PD, Parkinsonâs disease; PP2A, protein phosphatase-2A; PTM, post-translational modification.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d29942e1 class=n-a></a><h2 class=main-title id=d30512>Competing interests</h2><p class=metadata-entry><a name=d29942e93 class=n-a></a><p id=d29942e95> The author declares that he has no competing interests.</p></p></div><div class=back-section><a name=d29942e1 class=n-a></a><h2 class=main-title id=d30514>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d29942e1320 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d31194>References</h2><div class="section ref-list"><a name=d29942e1320 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d29942e1327 class=n-a></a>Maroteaux L, Scheller RH: The rat brain synucleins; family of proteins transiently associated with neuronal membrane. <i>Brain Res Mol Brain Res.</i> 1991; <b>11</b>(3â4): 335â43. <a target=xrefwindow id=d29942e1335 href="http://www.ncbi.nlm.nih.gov/pubmed/1661825">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1338 href="http://dx.doi.org/10.1016/0169-328X(91)90043-W">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d29942e1347 class=n-a></a>Weinreb PH, Zhen W, Poon AW, <i> et al.</i>: NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. <i>Biochemistry.</i> 1996; <b>35</b>(43): 13709â15. <a target=xrefwindow id=d29942e1358 href="http://www.ncbi.nlm.nih.gov/pubmed/8901511">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1361 href="http://dx.doi.org/10.1021/bi961799n">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d29942e1370 class=n-a></a>Polymeropoulos MH, Lavedan C, Leroy E, <i> et al.</i>: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. <i>Science.</i> 1997; <b>276</b>(5321): 2045â7. <a target=xrefwindow id=d29942e1381 href="http://www.ncbi.nlm.nih.gov/pubmed/9197268">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1384 href="http://dx.doi.org/10.1126/science.276.5321.2045">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d29942e1393 class=n-a></a>Spillantini MG, Schmidt ML, Lee VM, <i> et al.</i>: <i>Alpha</i>-synuclein in Lewy bodies. <i>Nature.</i> 1997; <b>388</b>(6645): 839â40. <a target=xrefwindow id=d29942e1407 href="http://www.ncbi.nlm.nih.gov/pubmed/9278044">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1411 href="http://dx.doi.org/10.1038/42166">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d29942e1420 class=n-a></a>Lewy FH: Paralysis Agitans. Pathologische Anatomie. In: Lewandowski M (ed), <i>Handbuch der Neurologie</i>. Springer, Berlin, 1912; 920â933. </span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d29942e1433 class=n-a></a>Forno LS: Neuropathology of Parkinson's disease. <i>J Neuropathol Exp Neurol.</i> 1996; <b>55</b>(3): 259â72. <a target=xrefwindow id=d29942e1441 href="http://www.ncbi.nlm.nih.gov/pubmed/8786384">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1444 href="http://dx.doi.org/10.1097/00005072-199603000-00001">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d29942e1453 class=n-a></a>McKeith IG, Dickson DW, Lowe J, <i> et al.</i>: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. <i>Neurology.</i> 2005; <b>65</b>(12): 1863â72. <a target=xrefwindow id=d29942e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/16237129">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1467 href="http://dx.doi.org/10.1212/01.wnl.0000187889.17253.b1">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d29942e1476 class=n-a></a>Wakabayashi K, Yoshimoto M, Tsuji S, <i> et al.</i>: Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. <i>Neurosci Lett.</i> 1998; <b>249</b>(2â3): 180â2. <a target=xrefwindow id=d29942e1487 href="http://www.ncbi.nlm.nih.gov/pubmed/9682846">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1490 href="http://dx.doi.org/10.1016/S0304-3940(98)00407-8">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d29942e1499 class=n-a></a>Spillantini MG, Crowther RA, Jakes R, <i> et al.</i>: Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. <i>Neurosci Lett.</i> 1998; <b>251</b>(3): 205â8. <a target=xrefwindow id=d29942e1510 href="http://www.ncbi.nlm.nih.gov/pubmed/9726379">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1513 href="http://dx.doi.org/10.1016/S0304-3940(98)00504-7">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d29942e1522 class=n-a></a>Gai WP, Power JH, Blumbergs PC, <i> et al.</i>: Multiple-system atrophy: a new alpha-synuclein disease? <i>Lancet.</i> 1998; <b>352</b>(9127): 547â8. <a target=xrefwindow id=d29942e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/9716068">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1536 href="http://dx.doi.org/10.1016/S0140-6736(05)79256-4">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d29942e1545 class=n-a></a>Trojanowski JQ, Goedert M, Iwatsubo T, <i> et al.</i>: Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. <i>Cell Death Differ.</i> 1998; <b>5</b>(10): 832â7. <a target=xrefwindow id=d29942e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/10203692">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1559 href="http://dx.doi.org/10.1038/sj.cdd.4400432">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d29942e1569 class=n-a></a>Takeda A, Mallory M, Sundsmo M, <i> et al.</i>: Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. <i>Am J Pathol.</i> 1998; <b>152</b>(2): 367â72. <a target=xrefwindow id=d29942e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/9466562">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1583 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1857971">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d29942e1592 class=n-a></a>LÃ¼cking CB, Brice A: Alpha-synuclein and Parkinson's disease. <i>Cell Mol Life Sci.</i> 2000; <b>57</b>(13â14): 1894â908. <a target=xrefwindow id=d29942e1600 href="http://www.ncbi.nlm.nih.gov/pubmed/11215516">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1603 href="http://dx.doi.org/10.1007/PL00000671">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d29942e1612 class=n-a></a>Arawaka S, Saito Y, Murayama S, <i> et al.</i>: Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. <i>Neurology.</i> 1998; <b>51</b>(3): 887â9. <a target=xrefwindow id=d29942e1623 href="http://www.ncbi.nlm.nih.gov/pubmed/9748051">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1626 href="http://dx.doi.org/10.1212/WNL.51.3.887">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d29942e1635 class=n-a></a>Wakabayashi K, Matsumoto K, Takayama K, <i> et al.</i>: NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. <i>Neurosci Lett.</i> 1997; <b>239</b>(1): 45â8. <a target=xrefwindow id=d29942e1646 href="http://www.ncbi.nlm.nih.gov/pubmed/9547168">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1649 href="http://dx.doi.org/10.1016/S0304-3940(97)00891-4">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d29942e1658 class=n-a></a>Spillantini MG, Crowther RA, Jakes R, <i> et al.</i>: alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. <i>Proc Natl Acad Sci U S A.</i> 1998; <b>95</b>(11): 6469â73. <a target=xrefwindow id=d29942e1669 href="http://www.ncbi.nlm.nih.gov/pubmed/9600990">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1672 href="http://www.ncbi.nlm.nih.gov/pmc/articles/27806">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d29942e1681 class=n-a></a>Spillantini MG, Goedert M: The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. <i>Ann N Y Acad Sci.</i> 2000; <b>920</b>: 16â27. <a target=xrefwindow id=d29942e1689 href="http://www.ncbi.nlm.nih.gov/pubmed/11193145">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1692 href="http://dx.doi.org/10.1111/j.1749-6632.2000.tb06900.x">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d29942e1702 class=n-a></a>Goedert M: Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. <i>Philos Trans R Soc Lond B Biol Sci.</i> 1999; <b>354</b>(1386): 1101â18. <a target=xrefwindow id=d29942e1710 href="http://www.ncbi.nlm.nih.gov/pubmed/10434313">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1713 href="http://dx.doi.org/10.1098/rstb.1999.0466">Publisher Full Text </a> | <a target=xrefwindow id=d29942e1716 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1692614">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d29942e1725 class=n-a></a>Galvin JE, Lee VM, Trojanowski JQ: Synucleinopathies: clinical and pathological implications. <i>Arch Neurol.</i> 2001; <b>58</b>(2): 186â90. <a target=xrefwindow id=d29942e1733 href="http://www.ncbi.nlm.nih.gov/pubmed/11176955">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1736 href="http://dx.doi.org/10.1001/archneur.58.2.186">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d29942e1745 class=n-a></a>Trojanowski JQ, Lee VM: Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses. <i>Ann N Y Acad Sci.</i> 2003; <b>991</b>: 107â10. <a target=xrefwindow id=d29942e1753 href="http://www.ncbi.nlm.nih.gov/pubmed/12846979">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1756 href="http://dx.doi.org/10.1111/j.1749-6632.2003.tb07468.x">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d29942e1765 class=n-a></a>Lundvig D, Lindersson E, Jensen PH: Pathogenic effects of alpha-synuclein aggregation. <i>Brain Res Mol Brain Res.</i> 2005; <b>134</b>(1): 3â17. <a target=xrefwindow id=d29942e1773 href="http://www.ncbi.nlm.nih.gov/pubmed/15790525">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1776 href="http://dx.doi.org/10.1016/j.molbrainres.2004.09.001">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d29942e1785 class=n-a></a>den Hartog Jager WA, Bethlem J: The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. <i>J Neurol Neurosurg Psychiatry.</i> 1960; <b>23</b>(4): 283â90. <a target=xrefwindow id=d29942e1793 href="http://www.ncbi.nlm.nih.gov/pubmed/13711997">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1796 href="http://dx.doi.org/10.1136/jnnp.23.4.283">Publisher Full Text </a> | <a target=xrefwindow id=d29942e1799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/497426">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d29942e1808 class=n-a></a>Kosaka K: Lewy bodies in cerebral cortex, report of three cases. <i>Acta Neuropathol.</i> 1978; <b>42</b>(2): 127â34. <a target=xrefwindow id=d29942e1816 href="http://www.ncbi.nlm.nih.gov/pubmed/654884">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1819 href="http://dx.doi.org/10.1007/BF00690978 ">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d29942e1829 class=n-a></a>Kosaka K, Mehraein P: Dementia-Parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. <i>Arch Psychiatr Nervenkr (1970).</i> 1979; <b>226</b>(4): 241â50. <a target=xrefwindow id=d29942e1837 href="http://www.ncbi.nlm.nih.gov/pubmed/222231">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1840 href="http://dx.doi.org/10.1007/BF00342237">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727399654"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e1849 class=n-a></a>Seidel K, Mahlke J, Siswanto S, <i> et al.</i>: The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies. <i>Brain Pathol.</i> 2015; <b>25</b>(2): 121â35. <a target=xrefwindow id=d29942e1860 href="http://www.ncbi.nlm.nih.gov/pubmed/24995389">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1863 href="http://dx.doi.org/10.1111/bpa.12168">Publisher Full Text </a> | <a target=xrefwindow id=d29942e1867 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4397912">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727399654">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725373935"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e1880 class=n-a></a>Roberts RF, Wade-Martins R, Alegre-Abarrategui J: Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain. <i>Brain.</i> 2015; <b>138</b>(Pt 6): 1642â57. <a target=xrefwindow id=d29942e1888 href="http://www.ncbi.nlm.nih.gov/pubmed/25732184">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1891 href="http://dx.doi.org/10.1093/brain/awv040">Publisher Full Text </a> | <a target=xrefwindow id=d29942e1894 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4614141">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725373935">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d29942e1907 class=n-a></a>Iwai A, Masliah E, Yoshimoto M, <i> et al.</i>: The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. <i>Neuron.</i> 1995; <b>14</b>(2): 467â75. <a target=xrefwindow id=d29942e1918 href="http://www.ncbi.nlm.nih.gov/pubmed/7857654">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1921 href="http://dx.doi.org/10.1016/0896-6273(95)90302-X">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d29942e1930 class=n-a></a>PoÃ§as GM, Branco-Santos J, Herrera F, <i> et al.</i>: Î±-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in <i>Drosophila</i>. <i>Hum Mol Genet.</i> 2015; <b>24</b>(7): 1898â907. <a target=xrefwindow id=d29942e1944 href="http://www.ncbi.nlm.nih.gov/pubmed/25452431">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1948 href="http://dx.doi.org/10.1093/hmg/ddu606">Publisher Full Text </a> | <a target=xrefwindow id=d29942e1951 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4355023">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d29942e1960 class=n-a></a>Sengupta U, Guerrero-MuÃ±oz MJ, Castillo-Carranza DL, <i> et al.</i>: Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. <i>Biol Psychiatry.</i> 2015; <b>78</b>(10): 672â83. <a target=xrefwindow id=d29942e1971 href="http://www.ncbi.nlm.nih.gov/pubmed/25676491">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1974 href="http://dx.doi.org/10.1016/j.biopsych.2014.12.019">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d29942e1984 class=n-a></a>Choi BK, Kim JY, Cha MY, <i> et al.</i>: Î²-Amyloid and Î±-synuclein cooperate to block SNARE-dependent vesicle fusion. <i>Biochemistry.</i> 2015; <b>54</b>(9): 1831â40. <a target=xrefwindow id=d29942e1995 href="http://www.ncbi.nlm.nih.gov/pubmed/25714795">PubMed Abstract </a> | <a target=xrefwindow id=d29942e1998 href="http://dx.doi.org/10.1021/acs.biochem.5b00087">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2002 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4414064">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d29942e2011 class=n-a></a>Bachhuber T, Katzmarski N, McCarter JF, <i> et al.</i>: Inhibition of amyloid-Î² plaque formation by Î±-synuclein. <i>Nat Med.</i> 2015; <b>21</b>(7): 802â7. <a target=xrefwindow id=d29942e2022 href="http://www.ncbi.nlm.nih.gov/pubmed/26099047">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2025 href="http://dx.doi.org/10.1038/nm.3885">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727011411"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e2034 class=n-a></a>Miki Y, Tanji K, Mori F, <i> et al.</i>: AMBRA1, a novel Î±-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy. <i>Brain Pathol.</i> 2016. <a target=xrefwindow id=d29942e2042 href="http://www.ncbi.nlm.nih.gov/pubmed/27875637">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2045 href="http://dx.doi.org/10.1111/bpa.12461">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727011411">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d29942e2058 class=n-a></a>Beadle GW, Tatum EL: Genetic Control of Biochemical Reactions in Neurospora. <i>Proc Natl Acad Sci U S A.</i> 1941; <b>27</b>(11): 499â506. <a target=xrefwindow id=d29942e2066 href="http://www.ncbi.nlm.nih.gov/pubmed/16588492">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2069 href="http://dx.doi.org/10.1073/pnas.27.11.499">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2072 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1078370">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d29942e2081 class=n-a></a>Dev KK, Hofele K, Barbieri S, <i> et al.</i>: Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. <i>Neuropharmacology.</i> 2003; <b>45</b>(1): 14â44. <a target=xrefwindow id=d29942e2092 href="http://www.ncbi.nlm.nih.gov/pubmed/12814657">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2095 href="http://dx.doi.org/10.1016/S0028-3908(03)00140-0">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726631149"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e2104 class=n-a></a>Ottolini D, CalÃ­ T, SzabÃ² I, <i> et al.</i>: Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications. <i>Biol Chem.</i> 2017; <b>398</b>(1): 77â100. <a target=xrefwindow id=d29942e2115 href="http://www.ncbi.nlm.nih.gov/pubmed/27508962">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2118 href="http://dx.doi.org/10.1515/hsz-2016-0201">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726631149">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d29942e2132 class=n-a></a>Uversky VN, Li J, Fink AL: Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. <i>J Biol Chem.</i> 2001; <b>276</b>(47): 44284â96. <a target=xrefwindow id=d29942e2140 href="http://www.ncbi.nlm.nih.gov/pubmed/11553618">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2143 href="http://dx.doi.org/10.1074/jbc.M105343200">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d29942e2152 class=n-a></a>Santner A, Uversky VN: Metalloproteomics and metal toxicology of Î±-synuclein. <i>Metallomics.</i> 2010; <b>2</b>(6): 378â92. <a target=xrefwindow id=d29942e2160 href="http://www.ncbi.nlm.nih.gov/pubmed/21072383">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2163 href="http://dx.doi.org/10.1039/b926659c">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d29942e2172 class=n-a></a>Ahmad A, Burns CS, Fink AL, <i> et al.</i>: Peculiarities of copper binding to alpha-synuclein. <i>J Biomol Struct Dyn.</i> 2012; <b>29</b>(4): 825â42. <a target=xrefwindow id=d29942e2183 href="http://www.ncbi.nlm.nih.gov/pubmed/22208282">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2186 href="http://dx.doi.org/10.1080/073911012010525023">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d29942e2195 class=n-a></a>Carboni E, Lingor P: Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease. <i>Metallomics.</i> 2015; <b>7</b>(3): 395â404. <a target=xrefwindow id=d29942e2203 href="http://www.ncbi.nlm.nih.gov/pubmed/25648629">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2206 href="http://dx.doi.org/10.1039/c4mt00339j">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d29942e2215 class=n-a></a>Uversky VN, Li J, Bower K, <i> et al.</i>: Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. <i>Neurotoxicology.</i> 2002; <b>23</b>(4â5): 527â36. <a target=xrefwindow id=d29942e2226 href="http://www.ncbi.nlm.nih.gov/pubmed/12428725">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2229 href="http://dx.doi.org/10.1016/S0161-813X(02)00067-0">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d29942e2238 class=n-a></a>Uversky VN, Li J, Fink AL: Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. <i>FEBS Lett.</i> 2001; <b>500</b>(3): 105â8. <a target=xrefwindow id=d29942e2246 href="http://www.ncbi.nlm.nih.gov/pubmed/11445065">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2249 href="http://dx.doi.org/10.1016/S0014-5793(01)02597-2">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d29942e2259 class=n-a></a>Maturana MG, Pinheiro AS, de Souza TL, <i> et al.</i>: Unveiling the role of the pesticides paraquat and rotenone on Î±-synuclein fibrillation <i>in vitro</i>. <i>Neurotoxicology.</i> 2015; <b>46</b>: 35â43. <a target=xrefwindow id=d29942e2273 href="http://www.ncbi.nlm.nih.gov/pubmed/25447323">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2277 href="http://dx.doi.org/10.1016/j.neuro.2014.11.006">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d29942e2286 class=n-a></a>Emanuele M, Chieregatti E: Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role. <i>Biomolecules.</i> 2015; <b>5</b>(2): 865â92. <a target=xrefwindow id=d29942e2294 href="http://www.ncbi.nlm.nih.gov/pubmed/25985082">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2297 href="http://dx.doi.org/10.3390/biom5020865">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2300 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4496700">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d29942e2309 class=n-a></a>da Costa CA, Ancolio K, Checler F: Wild-type but not Parkinson's disease-related ala-53 --&gt; Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli. <i>J Biol Chem.</i> 2000; <b>275</b>(31): 24065â9. <a target=xrefwindow id=d29942e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/10818098">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2320 href="http://dx.doi.org/10.1074/jbc.M002413200">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d29942e2329 class=n-a></a>Uversky VN: Alpha-synuclein misfolding and neurodegenerative diseases. <i>Curr Protein Pept Sci.</i> 2008; <b>9</b>(5): 507â40. <a target=xrefwindow id=d29942e2337 href="http://www.ncbi.nlm.nih.gov/pubmed/18855701">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2340 href="http://dx.doi.org/10.2174/138920308785915218">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d29942e2349 class=n-a></a>Payton JE, Perrin RJ, Clayton DF, <i> et al.</i>: Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells. <i>Brain Res Mol Brain Res.</i> 2001; <b>95</b>(1â2): 138â45. <a target=xrefwindow id=d29942e2360 href="http://www.ncbi.nlm.nih.gov/pubmed/11687285">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2363 href="http://dx.doi.org/10.1016/S0169-328X(01)00257-1">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d29942e2372 class=n-a></a>Jin J, Li GJ, Davis J, <i> et al.</i>: Identification of novel proteins associated with both alpha-synuclein and DJ-1. <i>Mol Cell Proteomics.</i> 2007; <b>6</b>(5): 845â59. <a target=xrefwindow id=d29942e2383 href="http://www.ncbi.nlm.nih.gov/pubmed/16854843">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2386 href="http://dx.doi.org/10.1074/mcp.M600182-MCP200">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d29942e2396 class=n-a></a>Abeliovich A, Schmitz Y, FariÃ±as I, <i> et al.</i>: Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. <i>Neuron.</i> 2000; <b>25</b>(1): 239â52. <a target=xrefwindow id=d29942e2407 href="http://www.ncbi.nlm.nih.gov/pubmed/10707987">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2410 href="http://dx.doi.org/10.1016/S0896-6273(00)80886-7">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d29942e2419 class=n-a></a>Cabin DE, Shimazu K, Murphy D, <i> et al.</i>: Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. <i>J Neurosci.</i> 2002; <b>22</b>(20): 8797â807. <a target=xrefwindow id=d29942e2430 href="http://www.ncbi.nlm.nih.gov/pubmed/12388586">PubMed Abstract </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d29942e2439 class=n-a></a>Yavich L, JÃ¤kÃ¤lÃ¤ P, Tanila H: Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. <i>J Neurochem.</i> 2006; <b>99</b>(3): 724â32. <a target=xrefwindow id=d29942e2447 href="http://www.ncbi.nlm.nih.gov/pubmed/16824047">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2450 href="http://dx.doi.org/10.1111/j.1471-4159.2006.04098.x">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d29942e2459 class=n-a></a>Oksman M, Tanila H, Yavich L: Brain reward in the absence of alpha-synuclein. <i>Neuroreport.</i> 2006; <b>17</b>(11): 1191â4. <a target=xrefwindow id=d29942e2467 href="http://www.ncbi.nlm.nih.gov/pubmed/16837852">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2470 href="http://dx.doi.org/10.1097/01.wnr.0000230507.70843.51">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726682883"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e2479 class=n-a></a>Ettle B, Kuhbandner K, JÃ¶rg S, <i> et al.</i>: Î±-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses. <i>J Neuroinflammation.</i> 2016; <b>13</b>(1): 201. <a target=xrefwindow id=d29942e2490 href="http://www.ncbi.nlm.nih.gov/pubmed/27565429">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2493 href="http://dx.doi.org/10.1186/s12974-016-0694-4">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2497 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5002168">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726682883">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1009752"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e2510 class=n-a></a>Dauer W, Kholodilov N, Vila M, <i> et al.</i>: Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. <i>Proc Natl Acad Sci U S A.</i> 2002; <b>99</b>(22): 14524â9. <a target=xrefwindow id=d29942e2521 href="http://www.ncbi.nlm.nih.gov/pubmed/12376616">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2524 href="http://dx.doi.org/10.1073/pnas.172514599">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2528 href="http://www.ncbi.nlm.nih.gov/pmc/articles/137916">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1009752">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d29942e2542 class=n-a></a>Robertson DC, Schmidt O, Ninkina N, <i> et al.</i>: Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. <i>J Neurochem.</i> 2004; <b>89</b>(5): 1126â36. <a target=xrefwindow id=d29942e2553 href="http://www.ncbi.nlm.nih.gov/pubmed/15147505">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2556 href="http://dx.doi.org/10.1111/j.1471-4159.2004.02378.x">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d29942e2565 class=n-a></a>Drolet RE, Behrouz B, Lookingland KJ, <i> et al.</i>: Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. <i>Neurotoxicology.</i> 2004; <b>25</b>(5): 761â9. <a target=xrefwindow id=d29942e2576 href="http://www.ncbi.nlm.nih.gov/pubmed/15288507">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2579 href="http://dx.doi.org/10.1016/j.neuro.2004.05.002">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d29942e2588 class=n-a></a>Golovko MY, Faergeman NJ, Cole NB, <i> et al.</i>: Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. <i>Biochemistry.</i> 2005; <b>44</b>(23): 8251â9. <a target=xrefwindow id=d29942e2599 href="http://www.ncbi.nlm.nih.gov/pubmed/15938614">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2602 href="http://dx.doi.org/10.1021/bi0502137">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d29942e2611 class=n-a></a>Golovko MY, Rosenberger TA, Feddersen S, <i> et al.</i>: Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. <i>J Neurochem.</i> 2007; <b>101</b>(1): 201â11. <a target=xrefwindow id=d29942e2622 href="http://www.ncbi.nlm.nih.gov/pubmed/17250657">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2625 href="http://dx.doi.org/10.1111/j.1471-4159.2006.04357.x">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d29942e2634 class=n-a></a>Golovko MY, Rosenberger TA, Faergeman NJ, <i> et al.</i>: Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. <i>Biochemistry.</i> 2006; <b>45</b>(22): 6956â66. <a target=xrefwindow id=d29942e2645 href="http://www.ncbi.nlm.nih.gov/pubmed/16734431">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2648 href="http://dx.doi.org/10.1021/bi0600289">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2652 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2532510">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d29942e2661 class=n-a></a>BarcelÃ³-Coblijn G, Golovko MY, Weinhofer I, <i> et al.</i>: Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice. <i>J Neurochem.</i> 2007; <b>101</b>(1): 132â41. <a target=xrefwindow id=d29942e2672 href="http://www.ncbi.nlm.nih.gov/pubmed/17250686">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2675 href="http://dx.doi.org/10.1111/j.1471-4159.2006.04348.x">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d29942e2685 class=n-a></a>Kermer P, KÃ¶hn A, Schnieder M, <i> et al.</i>: BAG1 is neuroprotective in <i>in vivo</i> and <i>in vitro</i> models of Parkinson's disease. <i>J Mol Neurosci.</i> 2015; <b>55</b>(3): 587â95. <a target=xrefwindow id=d29942e2703 href="http://www.ncbi.nlm.nih.gov/pubmed/25106480">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2706 href="http://dx.doi.org/10.1007/s12031-014-0396-2">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d29942e2715 class=n-a></a>Savolainen MH, Yan X, MyÃ¶hÃ¤nen TT, <i> et al.</i>: Prolyl oligopeptidase enhances Î±-synuclein dimerization via direct protein-protein interaction. <i>J Biol Chem.</i> 2015; <b>290</b>(8): 5117â26. <a target=xrefwindow id=d29942e2726 href="http://www.ncbi.nlm.nih.gov/pubmed/25555914">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2729 href="http://dx.doi.org/10.1074/jbc.M114.592931">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2733 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4335246">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d29942e2742 class=n-a></a>Betzer C, Movius AJ, Shi M, <i> et al.</i>: Identification of synaptosomal proteins binding to monomeric and oligomeric Î±-synuclein. <i>PLoS One.</i> 2015; <b>10</b>(2): e0116473. <a target=xrefwindow id=d29942e2753 href="http://www.ncbi.nlm.nih.gov/pubmed/25659148">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2756 href="http://dx.doi.org/10.1371/journal.pone.0116473">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2760 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4319895">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d29942e2769 class=n-a></a>Guardia-Laguarta C, Area-Gomez E, Schon EA, <i> et al.</i>: Novel subcellular localization for Î±-synuclein: possible functional consequences. <i>Front Neuroanat.</i> 2015; <b>9</b>: 17. <a target=xrefwindow id=d29942e2780 href="http://www.ncbi.nlm.nih.gov/pubmed/25755636">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2783 href="http://dx.doi.org/10.3389/fnana.2015.00017">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2787 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4337379">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726713551"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e2796 class=n-a></a>Chai YJ, Sierecki E, Tomatis VM, <i> et al.</i>: Munc18-1 is a molecular chaperone for Î±-synuclein, controlling its self-replicating aggregation. <i>J Cell Biol.</i> 2016; <b>214</b>(6): 705â18. <a target=xrefwindow id=d29942e2807 href="http://www.ncbi.nlm.nih.gov/pubmed/27597756">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2810 href="http://dx.doi.org/10.1083/jcb.201512016">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2814 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5021092">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726713551">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d29942e2827 class=n-a></a>Zaltieri M, Grigoletto J, Longhena F, <i> et al.</i>: Î±-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. <i>J Cell Sci.</i> 2015; <b>128</b>(13): 2231â43. <a target=xrefwindow id=d29942e2838 href="http://www.ncbi.nlm.nih.gov/pubmed/25967550">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2841 href="http://dx.doi.org/10.1242/jcs.157867">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d29942e2851 class=n-a></a>Rostovtseva TK, Gurnev PA, Protchenko O, <i> et al.</i>: Î±-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease. <i>J Biol Chem.</i> 2015; <b>290</b>(30): 18467â77. <a target=xrefwindow id=d29942e2862 href="http://www.ncbi.nlm.nih.gov/pubmed/26055708">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2865 href="http://dx.doi.org/10.1074/jbc.M115.641746">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2869 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4513106">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d29942e2878 class=n-a></a>Kakish J, Tavassoly O, Lee JS: Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to Î±-synuclein. <i>ACS Chem Neurosci.</i> 2015; <b>6</b>(2): 347â55. <a target=xrefwindow id=d29942e2886 href="http://www.ncbi.nlm.nih.gov/pubmed/25514361">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2889 href="http://dx.doi.org/10.1021/cn5002914">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d29942e2898 class=n-a></a>Jinsmaa Y, Cooney A, Sullivan P, <i> et al.</i>: The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein. <i>Neurosci Lett.</i> 2015; <b>590</b>: 134â7. <a target=xrefwindow id=d29942e2909 href="http://www.ncbi.nlm.nih.gov/pubmed/25637699">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2912 href="http://dx.doi.org/10.1016/j.neulet.2015.01.064">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4755587">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d29942e2925 class=n-a></a>Schapansky J, Nardozzi JD, LaVoie MJ: The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. <i>Neuroscience.</i> 2015; <b>302</b>: 74â88. <a target=xrefwindow id=d29942e2933 href="http://www.ncbi.nlm.nih.gov/pubmed/25284317">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2936 href="http://dx.doi.org/10.1016/j.neuroscience.2014.09.049">Publisher Full Text </a> | <a target=xrefwindow id=d29942e2939 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4383729">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d29942e2948 class=n-a></a>Zhang H, Duan C, Yang H: Defective autophagy in Parkinson's disease: lessons from genetics. <i>Mol Neurobiol.</i> 2015; <b>51</b>(1): 89â104. <a target=xrefwindow id=d29942e2956 href="http://www.ncbi.nlm.nih.gov/pubmed/24990317">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2959 href="http://dx.doi.org/10.1007/s12035-014-8787-5">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d29942e2968 class=n-a></a>Mishra AK, ur Rasheed MS, Shukla S, <i> et al.</i>: Aberrant autophagy and parkinsonism: does correction rescue from disease progression? <i>Mol Neurobiol.</i> 2015; <b>51</b>(3): 893â908. <a target=xrefwindow id=d29942e2979 href="http://www.ncbi.nlm.nih.gov/pubmed/24833602">PubMed Abstract </a> | <a target=xrefwindow id=d29942e2982 href="http://dx.doi.org/10.1007/s12035-014-8744-3">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d29942e2992 class=n-a></a>Allen Reish HE, Standaert DG: Role of Î±-synuclein in inducing innate and adaptive immunity in Parkinson disease. <i>J Parkinsons Dis.</i> 2015; <b>5</b>(1): 1â19. <a target=xrefwindow id=d29942e3000 href="http://www.ncbi.nlm.nih.gov/pubmed/25588354">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3003 href="http://dx.doi.org/10.3233/JPD-140491">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3006 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4405142">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d29942e3015 class=n-a></a>Shi Z, Sachs JN, Rhoades E, <i> et al.</i>: Biophysics of Î±-synuclein induced membrane remodelling. <i>Phys Chem Chem Phys.</i> 2015; <b>17</b>(24): 15561â8. <a target=xrefwindow id=d29942e3026 href="http://www.ncbi.nlm.nih.gov/pubmed/25665896">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3029 href="http://dx.doi.org/10.1039/C4CP05883F">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3033 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4464955">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726596301"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3042 class=n-a></a>Fakhree MA, Zijlstra N, Raiss CC, <i> et al.</i>: The number of Î±-synuclein proteins per vesicle gives insights into its physiological function. <i>Sci Rep.</i> 2016; <b>6</b>: 30658. <a target=xrefwindow id=d29942e3053 href="http://www.ncbi.nlm.nih.gov/pubmed/27477055">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3056 href="http://dx.doi.org/10.1038/srep30658">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3060 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4967914">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726596301">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d29942e3073 class=n-a></a>Breda C, Nugent ML, Estranero JG, <i> et al.</i>: Rab11 modulates Î±-synuclein-mediated defects in synaptic transmission and behaviour. <i>Hum Mol Genet.</i> 2015; <b>24</b>(4): 1077â91. <a target=xrefwindow id=d29942e3084 href="http://www.ncbi.nlm.nih.gov/pubmed/25305083">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3087 href="http://dx.doi.org/10.1093/hmg/ddu521">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3091 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4986550">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d29942e3100 class=n-a></a>Volpicelli-Daley LA: Effects of Î±-synuclein on axonal transport. <i>Neurobiol Dis.</i> 2016; pii: S0969-9961(16)30289-3. <a target=xrefwindow id=d29942e3105 href="http://www.ncbi.nlm.nih.gov/pubmed/27956085">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3108 href="http://dx.doi.org/10.1016/j.nbd.2016.12.008">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d29942e3117 class=n-a></a>Norris KL, Hao R, Chen L, <i> et al.</i>: Convergence of Parkin, PINK1, and Î±-Synuclein on Stress-induced Mitochondrial Morphological Remodeling. <i>J Biol Chem.</i> 2015; <b>290</b>(22): 13862â74. <a target=xrefwindow id=d29942e3128 href="http://www.ncbi.nlm.nih.gov/pubmed/25861987">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3131 href="http://dx.doi.org/10.1074/jbc.M114.634063">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3135 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4447961">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d29942e3145 class=n-a></a>Guardia-Laguarta C, Area-Gomez E, Schon EA, <i> et al.</i>: A new role for Î±-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication. <i>Mov Disord.</i> 2015; <b>30</b>(8): 1026â33. <a target=xrefwindow id=d29942e3156 href="http://www.ncbi.nlm.nih.gov/pubmed/25952565">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3159 href="http://dx.doi.org/10.1002/mds.26239">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726740144"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3168 class=n-a></a>Cartelli D, Aliverti A, Barbiroli A, <i> et al.</i>: alpha-Synuclein is a Novel Microtubule Dynamase. <i>Sci Rep.</i> 2016; <b>6</b>: 33289. <a target=xrefwindow id=d29942e3179 href="http://www.ncbi.nlm.nih.gov/pubmed/27628239">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3182 href="http://dx.doi.org/10.1038/srep33289">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3186 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5024109">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726740144">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725371347"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3199 class=n-a></a>Credle JJ, Forcelli PA, Delannoy M, <i> et al.</i>: alpha-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. <i>Neurobiol Dis.</i> 2015; <b>76</b>: 112â25. <a target=xrefwindow id=d29942e3210 href="http://www.ncbi.nlm.nih.gov/pubmed/25725420">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3213 href="http://dx.doi.org/10.1016/j.nbd.2015.02.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725371347">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726640489"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3226 class=n-a></a>Park SC, Moon JC, Shin SY, <i> et al.</i>: Functional characterization of alpha-synuclein protein with antimicrobial activity. <i>Biochem Biophys Res Commun.</i> 2016; <b>478</b>(2): 924â8. <a target=xrefwindow id=d29942e3237 href="http://www.ncbi.nlm.nih.gov/pubmed/27520375">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3240 href="http://dx.doi.org/10.1016/j.bbrc.2016.08.052">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726640489">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727495788"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3253 class=n-a></a>Kumar A, Leinisch F, Kadiiska MB, <i> et al.</i>: Formation and Implications of Alpha-Synuclein Radical in Maneb- and Paraquat-Induced Models of Parkinson's Disease. <i>Mol Neurobiol.</i> 2016; <b>53</b>(5): 2983â94. <a target=xrefwindow id=d29942e3264 href="http://www.ncbi.nlm.nih.gov/pubmed/25952542">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3267 href="http://dx.doi.org/10.1007/s12035-015-9179-1">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3271 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4637265">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727495788">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d29942e3284 class=n-a></a>Gispert S, Kurz A, Brehm N, <i> et al.</i>: Complexin-1 and Foxp1 Expression Changes Are Novel Brain Effects of Alpha-Synuclein Pathology. <i>Mol Neurobiol.</i> 2015; <b>52</b>(1): 57â63. <a target=xrefwindow id=d29942e3295 href="http://www.ncbi.nlm.nih.gov/pubmed/25112678">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3298 href="http://dx.doi.org/10.1007/s12035-014-8844-0">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3302 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4510914">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726917416"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3312 class=n-a></a>Sugeno N, JÃ¤ckel S, Voigt A, <i> et al.</i>: Î±-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses. <i>Sci Rep.</i> 2016; <b>6</b>: 36328. <a target=xrefwindow id=d29942e3323 href="http://www.ncbi.nlm.nih.gov/pubmed/27808254">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3326 href="http://dx.doi.org/10.1038/srep36328">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3330 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5093762">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726917416">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d29942e3343 class=n-a></a>Liang W, Miao S, Zhang B, <i> et al.</i>: Synuclein Î³ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption. <i>Oncogene.</i> 2015; <b>34</b>(18): 2398â405. <a target=xrefwindow id=d29942e3354 href="http://www.ncbi.nlm.nih.gov/pubmed/24954510">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3357 href="http://dx.doi.org/10.1038/onc.2014.126">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d29942e3366 class=n-a></a>Hua G, Xiaolei L, Weiwei Y, <i> et al.</i>: Protein phosphatase 2A is involved in the tyrosine hydroxylase phosphorylation regulated by Î±-synuclein. <i>Neurochem Res.</i> 2015; <b>40</b>(3): 428â37. <a target=xrefwindow id=d29942e3377 href="http://www.ncbi.nlm.nih.gov/pubmed/25567480">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3380 href="http://dx.doi.org/10.1007/s11064-014-1477-x">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d29942e3389 class=n-a></a>Navarria L, Zaltieri M, Longhena F, <i> et al.</i>: Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure. <i>Neurochem Int.</i> 2015; <b>85â86</b>: 14â23. <a target=xrefwindow id=d29942e3400 href="http://www.ncbi.nlm.nih.gov/pubmed/25846226">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3403 href="http://dx.doi.org/10.1016/j.neuint.2015.03.008">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d29942e3412 class=n-a></a>Baek HJ, Yoon JH, Ann EJ, <i> et al.</i>: Alpha-synuclein negatively regulates Notch1 intracellular domain protein stability through promoting interaction with Fbw7. <i>Neurosci Lett.</i> 2015; <b>600</b>: 6â11. <a target=xrefwindow id=d29942e3423 href="http://www.ncbi.nlm.nih.gov/pubmed/26033182">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3426 href="http://dx.doi.org/10.1016/j.neulet.2015.05.053">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d29942e3435 class=n-a></a>Clayton DF, George JM: Synucleins in synaptic plasticity and neurodegenerative disorders. <i>J Neurosci Res.</i> 1999; <b>58</b>(1): 120â9. <a target=xrefwindow id=d29942e3443 href="http://www.ncbi.nlm.nih.gov/pubmed/10491577">PubMed Abstract </a> | <a target="xrefwindow" id="d29942e3446" href="http://dx.doi.org/10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12&gt;3.0.CO;2-E">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d29942e3456 class=n-a></a>UÃ©da K, Fukushima H, Masliah E, <i> et al.</i>: Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. <i>Proc Natl Acad Sci U S A.</i> 1993; <b>90</b>(23): 11282â6. <a target=xrefwindow id=d29942e3467 href="http://www.ncbi.nlm.nih.gov/pubmed/8248242">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3470 href="http://dx.doi.org/10.1073/pnas.90.23.11282">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3474 href="http://www.ncbi.nlm.nih.gov/pmc/articles/47966">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d29942e3483 class=n-a></a>Maroteaux L, Campanelli JT, Scheller RH: Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. <i>J Neurosci.</i> 1988; <b>8</b>(8): 2804â15. <a target=xrefwindow id=d29942e3491 href="http://www.ncbi.nlm.nih.gov/pubmed/3411354">PubMed Abstract </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d29942e3500 class=n-a></a>Jakes R, Spillantini MG, Goedert M: Identification of two distinct synucleins from human brain. <i>FEBS Lett.</i> 1994; <b>345</b>(1): 27â32. <a target=xrefwindow id=d29942e3508 href="http://www.ncbi.nlm.nih.gov/pubmed/8194594">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3511 href="http://dx.doi.org/10.1016/0014-5793(94)00395-5">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d29942e3520 class=n-a></a>Nakajo S, Tsukada K, Omata K, <i> et al.</i>: A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. <i>Eur J Biochem.</i> 1993; <b>217</b>(3): 1057â63. <a target=xrefwindow id=d29942e3531 href="http://www.ncbi.nlm.nih.gov/pubmed/8223629">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3534 href="http://dx.doi.org/10.1111/j.1432-1033.1993.tb18337.x">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d29942e3543 class=n-a></a>Tobe T, Nakajo S, Tanaka A, <i> et al.</i>: Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein. <i>J Neurochem.</i> 1992; <b>59</b>(5): 1624â9. <a target=xrefwindow id=d29942e3554 href="http://www.ncbi.nlm.nih.gov/pubmed/1402909">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3557 href="http://dx.doi.org/10.1111/j.1471-4159.1992.tb10991.x">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d29942e3566 class=n-a></a>Ji H, Liu YE, Jia T, <i> et al.</i>: Identification of a breast cancer-specific gene, <i>BCSG1</i>, by direct differential cDNA sequencing. <i>Cancer Res.</i> 1997; <b>57</b>(4): 759â64. <a target=xrefwindow id=d29942e3580 href="http://www.ncbi.nlm.nih.gov/pubmed/9044857">PubMed Abstract </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d29942e3590 class=n-a></a>Ninkina N, Alimova-Kost MV, Paterson JW, <i> et al.</i>: Organization, expression and polymorphism of the human <i>persyn</i> gene. <i>Hum Mol Genet.</i> 1998; <b>7</b>(9): 1417â24. <a target=xrefwindow id=d29942e3604 href="http://www.ncbi.nlm.nih.gov/pubmed/9700196">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3608 href="http://dx.doi.org/10.1093/hmg/7.9.1417">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d29942e3617 class=n-a></a>Buchman VL, Hunter HJ, PinÃµn LG, <i> et al.</i>: Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. <i>J Neurosci.</i> 1998; <b>18</b>(22): 9335â41. <a target=xrefwindow id=d29942e3628 href="http://www.ncbi.nlm.nih.gov/pubmed/9801372">PubMed Abstract </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d29942e3637 class=n-a></a>Lavedan C, Leroy E, Dehejia A, <i> et al.</i>: Identification, localization and characterization of the human gamma-synuclein gene. <i>Hum Genet.</i> 1998; <b>103</b>(1): 106â12. <a target=xrefwindow id=d29942e3648 href="http://www.ncbi.nlm.nih.gov/pubmed/9737786">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3651 href="http://dx.doi.org/10.1007/s004390050792">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d29942e3660 class=n-a></a>Clayton DF, George JM: The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. <i>Trends Neurosci.</i> 1998; <b>21</b>(6): 249â54. <a target=xrefwindow id=d29942e3668 href="http://www.ncbi.nlm.nih.gov/pubmed/9641537">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3671 href="http://dx.doi.org/10.1016/S0166-2236(97)01213-7">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d29942e3680 class=n-a></a>Galvin JE, Uryu K, Lee VM, <i> et al.</i>: Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. <i>Proc Natl Acad Sci U S A.</i> 1999; <b>96</b>(23): 13450â5. <a target=xrefwindow id=d29942e3691 href="http://www.ncbi.nlm.nih.gov/pubmed/10557341">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3694 href="http://dx.doi.org/10.1073/pnas.96.23.13450">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3698 href="http://www.ncbi.nlm.nih.gov/pmc/articles/23968">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d29942e3707 class=n-a></a>Uversky VN, Li J, Souillac P, <i> et al.</i>: Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. <i>J Biol Chem.</i> 2002; <b>277</b>(14): 11970â8. <a target=xrefwindow id=d29942e3718 href="http://www.ncbi.nlm.nih.gov/pubmed/11812782">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3721 href="http://dx.doi.org/10.1074/jbc.M109541200">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d29942e3731 class=n-a></a>Yamin G, Munishkina LA, Karymov MA, <i> et al.</i>: Forcing nonamyloidogenic beta-synuclein to fibrillate. <i>Biochemistry.</i> 2005; <b>44</b>(25): 9096â107. <a target=xrefwindow id=d29942e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/15966733">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3745 href="http://dx.doi.org/10.1021/bi048778a">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d29942e3754 class=n-a></a>Hashimoto M, Rockenstein E, Mante M, <i> et al.</i>: beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. <i>Neuron.</i> 2001; <b>32</b>(2): 213â23. <a target=xrefwindow id=d29942e3765 href="http://www.ncbi.nlm.nih.gov/pubmed/11683992">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3768 href="http://dx.doi.org/10.1016/S0896-6273(01)00462-7">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725857923"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3777 class=n-a></a>Janowska MK, Wu KP, Baum J: Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein. <i>Sci Rep.</i> 2015; <b>5</b>: 15164. <a target=xrefwindow id=d29942e3785 href="http://www.ncbi.nlm.nih.gov/pubmed/26477939">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3788 href="http://dx.doi.org/10.1038/srep15164">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4609965">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725857923">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726917485"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3804 class=n-a></a>Brown JW, Buell AK, Michaels TC, <i> et al.</i>: <i>Î²</i>-Synuclein suppresses both the initiation and amplification steps of <i>Î±</i>-synuclein aggregation via competitive binding to surfaces. <i>Sci Rep.</i> 2016; <b>6</b>: 36010. <a target=xrefwindow id=d29942e3822 href="http://www.ncbi.nlm.nih.gov/pubmed/27808107">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3825 href="http://dx.doi.org/10.1038/srep36010">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3828 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5093550">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726917485">F1000 Recommendation</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d29942e3841 class=n-a></a>Tolmasov M, Djaldetti R, Lev N, <i> et al.</i>: Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders. <i>Expert Rev Neurother.</i> 2016; <b>16</b>(5): 505â13. <a target=xrefwindow id=d29942e3852 href="http://www.ncbi.nlm.nih.gov/pubmed/26959397">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3855 href="http://dx.doi.org/10.1586/14737175.2016.1164600">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d29942e3864 class=n-a></a>Chandra S, Fornai F, Kwon H, <i> et al.</i>: Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. <i>Proc Natl Acad Sci U S A.</i> 2004; <b>101</b>(41): 14966â71. <a target=xrefwindow id=d29942e3875 href="http://www.ncbi.nlm.nih.gov/pubmed/15465911">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3878 href="http://dx.doi.org/10.1073/pnas.0406283101">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3882 href="http://www.ncbi.nlm.nih.gov/pmc/articles/522043">Free Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727165064"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3892 class=n-a></a>Vargas KJ, Schrod N, Davis T, <i> et al.</i>: Synucleins Have Multiple Effects on Presynaptic Architecture. <i>Cell Rep.</i> 2017; <b>18</b>(1): 161â73. <a target=xrefwindow id=d29942e3903 href="http://www.ncbi.nlm.nih.gov/pubmed/28052246">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3906 href="http://dx.doi.org/10.1016/j.celrep.2016.12.023">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727165064">F1000 Recommendation</a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726727793"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e3919 class=n-a></a>Connor-Robson N, Peters OM, Millership S, <i> et al.</i>: Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism. <i>Neurobiol Aging.</i> 2016; <b>46</b>: 107â12. <a target=xrefwindow id=d29942e3930 href="http://www.ncbi.nlm.nih.gov/pubmed/27614017">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3933 href="http://dx.doi.org/10.1016/j.neurobiolaging.2016.06.020">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3937 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5021248">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726727793">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d29942e3950 class=n-a></a>Kabaria S, Choi DC, Chaudhuri AD, <i> et al.</i>: Inhibition of miR-34b and miR-34c enhances Î±-synuclein expression in Parkinson's disease. <i>FEBS Lett.</i> 2015; <b>589</b>(3): 319â25. <a target=xrefwindow id=d29942e3961 href="http://www.ncbi.nlm.nih.gov/pubmed/25541488">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3964 href="http://dx.doi.org/10.1016/j.febslet.2014.12.014">Publisher Full Text </a> | <a target=xrefwindow id=d29942e3968 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4306645">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d29942e3977 class=n-a></a>FernÃ¡ndez-Santiago R, Iranzo A, Gaig C, <i> et al.</i>: MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder. <i>Ann Neurol.</i> 2015; <b>77</b>(5): 895â901. <a target=xrefwindow id=d29942e3988 href="http://www.ncbi.nlm.nih.gov/pubmed/25675938">PubMed Abstract </a> | <a target=xrefwindow id=d29942e3991 href="http://dx.doi.org/10.1002/ana.24384">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d29942e4000 class=n-a></a>PihlstrÃ¸m L, Berge V, Rengmark A, <i> et al.</i>: Parkinson's disease correlates with promoter methylation in the Î±-synuclein gene. <i>Mov Disord.</i> 2015; <b>30</b>(4): 577â80. <a target=xrefwindow id=d29942e4011 href="http://www.ncbi.nlm.nih.gov/pubmed/25545759">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4014 href="http://dx.doi.org/10.1002/mds.26073">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d29942e4023 class=n-a></a>Pavlou MA, Pinho R, Paiva I, <i> et al.</i>: The yin and yang of Î±-synuclein-associated epigenetics in Parkinson's disease. <i>Brain.</i> 2016; pii: aww227. <a target=xrefwindow id=d29942e4031 href="http://www.ncbi.nlm.nih.gov/pubmed/27585855">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4034 href="http://dx.doi.org/10.1093/brain/aww227">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d29942e4044 class=n-a></a>Breydo L, Morgan D, Uversky VN: Pseudocatalytic Antiaggregation Activity of Antibodies: Immunoglobulins can Influence Î±-Synuclein Aggregation at Substoichiometric Concentrations. <i>Mol Neurobiol.</i> 2016; <b>53</b>(3): 1949â58. <a target=xrefwindow id=d29942e4052 href="http://www.ncbi.nlm.nih.gov/pubmed/25833100">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4055 href="http://dx.doi.org/10.1007/s12035-015-9148-8">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726993966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4064 class=n-a></a>Sahin C, Lorenzen N, Lemminger L, <i> et al.</i>: Antibodies against the C-terminus of Î±-synuclein modulate its fibrillation. <i>Biophys Chem.</i> 2017; <b>220</b>: 34â41. <a target=xrefwindow id=d29942e4075 href="http://www.ncbi.nlm.nih.gov/pubmed/27863716">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4078 href="http://dx.doi.org/10.1016/j.bpc.2016.11.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726993966">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d29942e4091 class=n-a></a>Sluchanko NN, Gusev NB: Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins. <i>FEBS J.</i> 2016. <a target=xrefwindow id=d29942e4096 href="http://www.ncbi.nlm.nih.gov/pubmed/27973707">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4099 href="http://dx.doi.org/10.1111/febs.13986">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726603013"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4108 class=n-a></a>Wang W, Nguyen LT, Burlak C, <i> et al.</i>: Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein Î±-synuclein. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(34): 9587â92. <a target=xrefwindow id=d29942e4119 href="http://www.ncbi.nlm.nih.gov/pubmed/27482083">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4122 href="http://dx.doi.org/10.1073/pnas.1610099113">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4126 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5003239">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726603013">F1000 Recommendation</a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726578925"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4139 class=n-a></a>Jarvela TS, Lam HA, Helwig M, <i> et al.</i>: The neural chaperone proSAAS blocks Î±-synuclein fibrillation and neurotoxicity. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(32): E4708â15. <a target=xrefwindow id=d29942e4150 href="http://www.ncbi.nlm.nih.gov/pubmed/27457957">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4153 href="http://dx.doi.org/10.1073/pnas.1601091113">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4157 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4987805">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726578925">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d29942e4170 class=n-a></a>Lobbens ES, Breydo L, Skamris T, <i> et al.</i>: Mechanistic study of the inhibitory activity of <i>Geum urbanum</i> extract against Î±-Synuclein fibrillation. <i>Biochim Biophys Acta.</i> 2016; <b>1864</b>(9): 1160â9. <a target=xrefwindow id=d29942e4184 href="http://www.ncbi.nlm.nih.gov/pubmed/27353564">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4188 href="http://dx.doi.org/10.1016/j.bbapap.2016.06.009">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726319058"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4198 class=n-a></a>GonÃ§alves SA, Macedo D, Raquel H, <i> et al.</i>: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity. <i>PLoS Genet.</i> 2016; <b>12</b>(4): e1005995. <a target=xrefwindow id=d29942e4209 href="http://www.ncbi.nlm.nih.gov/pubmed/27123591">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4212 href="http://dx.doi.org/10.1371/journal.pgen.1005995">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4216 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4849646">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726319058">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725260287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4229 class=n-a></a>Ardah MT, Paleologou KE, Lv G, <i> et al.</i>: Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. <i>Neurobiol Dis.</i> 2015; <b>74</b>: 89â101. <a target=xrefwindow id=d29942e4240 href="http://www.ncbi.nlm.nih.gov/pubmed/25449909">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4243 href="http://dx.doi.org/10.1016/j.nbd.2014.11.007">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4247 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4882765">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725260287">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d29942e4260 class=n-a></a>Kunadt M, Eckermann K, Stuendl A, <i> et al.</i>: Extracellular vesicle sorting of Î±-Synuclein is regulated by sumoylation. <i>Acta Neuropathol.</i> 2015; <b>129</b>(5): 695â713. <a target=xrefwindow id=d29942e4271 href="http://www.ncbi.nlm.nih.gov/pubmed/25778619">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4274 href="http://dx.doi.org/10.1007/s00401-015-1408-1">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4278 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4405286">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d29942e4287 class=n-a></a>Fontaine SN, Zheng D, Sabbagh JJ, <i> et al.</i>: DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins. <i>EMBO J.</i> 2016; <b>35</b>(14): 1537â49. <a target=xrefwindow id=d29942e4298 href="http://www.ncbi.nlm.nih.gov/pubmed/27261198">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4301 href="http://dx.doi.org/10.15252/embj.201593489">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4305 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4946142">Free Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d29942e4314 class=n-a></a>Rousseaux MW, de Haro M, Lasagna-Reeves CA, <i> et al.</i>: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. <i>eLife.</i> 2016; <b>5</b>: pii: e19809. <a target=xrefwindow id=d29942e4325 href="http://www.ncbi.nlm.nih.gov/pubmed/27779468">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4328 href="http://dx.doi.org/10.7554/eLife.19809">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4332 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5104516">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d29942e4341 class=n-a></a>Pavlou MA, Colombo N, Fuertes-Alvarez S, <i> et al.</i>: Expression of the Parkinson's Disease-Associated Gene <i>Alpha-Synuclein</i> is Regulated by the Neuronal Cell Fate Determinant TRIM32. <i>Mol Neurobiol.</i> 2016; 1â14. <a target=xrefwindow id=d29942e4352 href="http://www.ncbi.nlm.nih.gov/pubmed/27339877">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4355 href="http://dx.doi.org/10.1007/s12035-016-9989-9">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726734668"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4365 class=n-a></a>Wong YC, Krainc D: Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease. <i>Mov Disord.</i> 2016; <b>31</b>(11): 1610â8. <a target=xrefwindow id=d29942e4373 href="http://www.ncbi.nlm.nih.gov/pubmed/27619775">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4376 href="http://dx.doi.org/10.1002/mds.26802">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726734668">F1000 Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d29942e4389 class=n-a></a>Uversky VN, Li J, Fink AL: Evidence for a partially folded intermediate in alpha-synuclein fibril formation. <i>J Biol Chem.</i> 2001; <b>276</b>(14): 10737â44. <a target=xrefwindow id=d29942e4397 href="http://www.ncbi.nlm.nih.gov/pubmed/11152691">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4400 href="http://dx.doi.org/10.1074/jbc.M010907200">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d29942e4409 class=n-a></a>Uversky VN: A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. <i>J Biomol Struct Dyn.</i> 2003; <b>21</b>(2): 211â34. <a target=xrefwindow id=d29942e4417 href="http://www.ncbi.nlm.nih.gov/pubmed/12956606">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4420 href="http://dx.doi.org/10.1080/07391102.2003.10506918">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d29942e4429 class=n-a></a>Fauvet B, Mbefo MK, Fares M, <i> et al.</i>: Î±-Synuclein in central nervous system and from erythrocytes, mammalian cells, and <i>Escherichia coli</i> exists predominantly as disordered monomer. <i>J Biol Chem.</i> 2012; <b>287</b>(19): 15345â64. <a target=xrefwindow id=d29942e4443 href="http://www.ncbi.nlm.nih.gov/pubmed/22315227">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4447 href="http://dx.doi.org/10.1074/jbc.M111.318949">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4450 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3346117">Free Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d29942e4459 class=n-a></a>Binolfi A, Theillet FX, Selenko P: Bacterial in-cell NMR of human Î±-synuclein: a disordered monomer by nature? <i>Biochem Soc Trans.</i> 2012; <b>40</b>(5): 950â4. <a target=xrefwindow id=d29942e4467 href="http://www.ncbi.nlm.nih.gov/pubmed/22988846">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4470 href="http://dx.doi.org/10.1042/BST20120096">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726099896"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4479 class=n-a></a>Theillet FX, Binolfi A, Bekei B, <i> et al.</i>: Structural disorder of monomeric Î±-synuclein persists in mammalian cells. <i>Nature.</i> 2016; <b>530</b>(7588): 45â50. <a target=xrefwindow id=d29942e4490 href="http://www.ncbi.nlm.nih.gov/pubmed/26808899">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4493 href="http://dx.doi.org/10.1038/nature16531">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726099896">F1000 Recommendation</a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d29942e4507 class=n-a></a>Gurry T, Ullman O, Fisher CK, <i> et al.</i>: The dynamic structure of Î±-synuclein multimers. <i>J Am Chem Soc.</i> 2013; <b>135</b>(10): 3865â72. <a target=xrefwindow id=d29942e4518 href="http://www.ncbi.nlm.nih.gov/pubmed/23398399">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4521 href="http://dx.doi.org/10.1021/ja310518p">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d29942e4530 class=n-a></a>Eliezer D, Kutluay E, Bussell R Jr, <i> et al.</i>: Conformational properties of alpha-synuclein in its free and lipid-associated states. <i>J Mol Biol.</i> 2001; <b>307</b>(4): 1061â73. <a target=xrefwindow id=d29942e4541 href="http://www.ncbi.nlm.nih.gov/pubmed/11286556">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4544 href="http://dx.doi.org/10.1006/jmbi.2001.4538">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d29942e4553 class=n-a></a>Uversky VN, Eliezer D: Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. <i>Curr Protein Pept Sci.</i> 2009; <b>10</b>(5): 483â99. <a target=xrefwindow id=d29942e4561 href="http://www.ncbi.nlm.nih.gov/pubmed/19538146">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4564 href="http://dx.doi.org/10.2174/138920309789351921">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4567 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3786709">Free Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d29942e4576 class=n-a></a>Uversky VN: Intrinsically disordered proteins may escape unwanted interactions via functional misfolding. <i>Biochim Biophys Acta.</i> 2011; <b>1814</b>(5): 693â712. <a target=xrefwindow id=d29942e4584 href="http://www.ncbi.nlm.nih.gov/pubmed/21440685">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4587 href="http://dx.doi.org/10.1016/j.bbapap.2011.03.010">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d29942e4596 class=n-a></a>Oueslati A, Fournier M, Lashuel HA: Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. <i>Prog Brain Res.</i> 2010; <b>183</b>: 115â45. <a target=xrefwindow id=d29942e4604 href="http://www.ncbi.nlm.nih.gov/pubmed/20696318">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4607 href="http://dx.doi.org/10.1016/S0079-6123(10)83007-9">Publisher Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d29942e4616 class=n-a></a>Schmid AW, Fauvet B, Moniatte M, <i> et al.</i>: Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies. <i>Mol Cell Proteomics.</i> 2013; <b>12</b>(12): 3543â58. <a target=xrefwindow id=d29942e4627 href="http://www.ncbi.nlm.nih.gov/pubmed/23966418">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4630 href="http://dx.doi.org/10.1074/mcp.R113.032730">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4634 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3861707">Free Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d29942e4644 class=n-a></a>Hejjaoui M, Haj-Yahya M, Kumar KS, <i> et al.</i>: Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated Î±-synuclein. <i>Angew Chem Int Ed Engl.</i> 2011; <b>50</b>(2): 405â9. <a target=xrefwindow id=d29942e4655 href="http://www.ncbi.nlm.nih.gov/pubmed/21154793">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4658 href="http://dx.doi.org/10.1002/anie.201005546">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d29942e4667 class=n-a></a>Hejjaoui M, Butterfield S, Fauvet B, <i> et al.</i>: Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: Î±-synuclein phosphorylation at tyrosine 125. <i>J Am Chem Soc.</i> 2012; <b>134</b>(11): 5196â210. <a target=xrefwindow id=d29942e4678 href="http://www.ncbi.nlm.nih.gov/pubmed/22339654">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4681 href="http://dx.doi.org/10.1021/ja210866j">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4685 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3592575">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718112968"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4694 class=n-a></a>Haj-Yahya M, Fauvet B, Herman-Bachinsky Y, <i> et al.</i>: Synthetic polyubiquitinated Î±-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(44): 17726â31. <a target=xrefwindow id=d29942e4705 href="http://www.ncbi.nlm.nih.gov/pubmed/24043770">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4708 href="http://dx.doi.org/10.1073/pnas.1315654110">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3816408">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718112968">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725388567"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4725 class=n-a></a>Burai R, Ait-Bouziad N, Chiki A, <i> et al.</i>: Elucidating the Role of Site-Specific Nitration of Î±-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis. <i>J Am Chem Soc.</i> 2015; <b>137</b>(15): 5041â52. <a target=xrefwindow id=d29942e4736 href="http://www.ncbi.nlm.nih.gov/pubmed/25768729">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4739 href="http://dx.doi.org/10.1021/ja5131726">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725388567">F1000 Recommendation</a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725875277"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4752 class=n-a></a>Fauvet B, Lashuel HA: Semisynthesis and Enzymatic Preparation of Post-translationally Modified Î±-Synuclein. <i>Methods Mol Biol.</i> 2016; <b>1345</b>: 3â20. <a target=xrefwindow id=d29942e4760 href="http://www.ncbi.nlm.nih.gov/pubmed/26453202">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4763 href="http://dx.doi.org/10.1007/978-1-4939-2978-8_1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725875277">F1000 Recommendation</a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d29942e4776 class=n-a></a>Kruger R, Kuhn W, MÃ¼ller T, <i> et al.</i>: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. <i>Nat Genet.</i> 1998; <b>18</b>(2): 106â8. <a target=xrefwindow id=d29942e4787 href="http://www.ncbi.nlm.nih.gov/pubmed/9462735">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4790 href="http://dx.doi.org/10.1038/ng0298-106">Publisher Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1017324"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e4800 class=n-a></a>Zarranz JJ, Alegre J, GÃ³mez-Esteban JC, <i> et al.</i>: The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. <i>Ann Neurol.</i> 2004; <b>55</b>(2): 164â73. <a target=xrefwindow id=d29942e4811 href="http://www.ncbi.nlm.nih.gov/pubmed/14755719">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4814 href="http://dx.doi.org/10.1002/ana.10795">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1017324">F1000 Recommendation</a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d29942e4827 class=n-a></a>Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, <i> et al.</i>: Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. <i>Mov Disord.</i> 2013; <b>28</b>(6): 811â3. <a target=xrefwindow id=d29942e4838 href="http://www.ncbi.nlm.nih.gov/pubmed/23457019">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4841 href="http://dx.doi.org/10.1002/mds.25421">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d29942e4850 class=n-a></a>Proukakis C, Dudzik CG, Brier T, <i> et al.</i>: A novel Î±-synuclein missense mutation in Parkinson disease. <i>Neurology.</i> 2013; <b>80</b>(11): 1062â4. <a target=xrefwindow id=d29942e4861 href="http://www.ncbi.nlm.nih.gov/pubmed/23427326">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4864 href="http://dx.doi.org/10.1212/WNL.0b013e31828727ba">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4868 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3653201">Free Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d29942e4877 class=n-a></a>Kiely AP, Asi YT, Kara E, <i> et al.</i>: Î±-Synucleinopathy associated with G51D <i>SNCA</i> mutation: a link between Parkinson's disease and multiple system atrophy? <i>Acta Neuropathol.</i> 2013; <b>125</b>(5): 753â69. <a target=xrefwindow id=d29942e4891 href="http://www.ncbi.nlm.nih.gov/pubmed/23404372">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4895 href="http://dx.doi.org/10.1007/s00401-013-1096-7">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3681325">Free Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d29942e4907 class=n-a></a>Lesage S, Anheim M, Letournel F, <i> et al.</i>: G51D Î±-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. <i>Ann Neurol.</i> 2013; <b>73</b>(4): 459â71. <a target=xrefwindow id=d29942e4918 href="http://www.ncbi.nlm.nih.gov/pubmed/23526723">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4921 href="http://dx.doi.org/10.1002/ana.23894">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d29942e4930 class=n-a></a>Pasanen P, Myllykangas L, Siitonen M, <i> et al.</i>: Novel Î±-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. <i>Neurobiol Aging.</i> 2014; <b>35</b>(9): 2180.e1â5. <a target=xrefwindow id=d29942e4941 href="http://www.ncbi.nlm.nih.gov/pubmed/24746362">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4944 href="http://dx.doi.org/10.1016/j.neurobiolaging.2014.03.024">Publisher Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d29942e4954 class=n-a></a>Li J, Uversky VN, Fink AL: Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. <i>Biochemistry.</i> 2001; <b>40</b>(38): 11604â13. <a target=xrefwindow id=d29942e4962 href="http://www.ncbi.nlm.nih.gov/pubmed/11560511">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4965 href="http://dx.doi.org/10.1021/bi010616g">Publisher Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a name=d29942e4974 class=n-a></a>Lemkau LR, Comellas G, Kloepper KD, <i> et al.</i>: Mutant protein A30P Î±-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics. <i>J Biol Chem.</i> 2012; <b>287</b>(14): 11526â32. <a target=xrefwindow id=d29942e4985 href="http://www.ncbi.nlm.nih.gov/pubmed/22334684">PubMed Abstract </a> | <a target=xrefwindow id=d29942e4988 href="http://dx.doi.org/10.1074/jbc.M111.306902">Publisher Full Text </a> | <a target=xrefwindow id=d29942e4992 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3322835">Free Full Text </a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d29942e5001 class=n-a></a>Conway KA, Harper JD, Lansbury PT: Accelerated <i>in vitro</i> fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. <i>Nat Med.</i> 1998; <b>4</b>(11): 1318â20. <a target=xrefwindow id=d29942e5012 href="http://www.ncbi.nlm.nih.gov/pubmed/9809558">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5015 href="http://dx.doi.org/10.1038/3311">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d29942e5024 class=n-a></a>Fredenburg RA, Rospigliosi C, Meray RK, <i> et al.</i>: The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. <i>Biochemistry.</i> 2007; <b>46</b>(24): 7107â18. <a target=xrefwindow id=d29942e5035 href="http://www.ncbi.nlm.nih.gov/pubmed/17530780">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5038 href="http://dx.doi.org/10.1021/bi7000246">Publisher Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d29942e5047 class=n-a></a>Pandey N, Schmidt RE, Galvin JE: The alpha-synuclein mutation E46K promotes aggregation in cultured cells. <i>Exp Neurol.</i> 2006; <b>197</b>(2): 515â20. <a target=xrefwindow id=d29942e5055 href="http://www.ncbi.nlm.nih.gov/pubmed/16325180">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5058 href="http://dx.doi.org/10.1016/j.expneurol.2005.10.019">Publisher Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718453230"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5067 class=n-a></a>Khalaf O, Fauvet B, Oueslati A, <i> et al.</i>: The H50Q mutation enhances Î±-synuclein aggregation, secretion, and toxicity. <i>J Biol Chem.</i> 2014; <b>289</b>(32): 21856â76. <a target=xrefwindow id=d29942e5078 href="http://www.ncbi.nlm.nih.gov/pubmed/24936070">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5081 href="http://dx.doi.org/10.1074/jbc.M114.553297">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5085 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4139205">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718453230">F1000 Recommendation</a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d29942e5099 class=n-a></a>Rutherford NJ, Moore BD, Golde TE, <i> et al.</i>: Divergent effects of the H50Q and G51D <i>SNCA</i> mutations on the aggregation of Î±-synuclein. <i>J Neurochem.</i> 2014; <b>131</b>(6): 859â67. <a target=xrefwindow id=d29942e5113 href="http://www.ncbi.nlm.nih.gov/pubmed/24984882">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5117 href="http://dx.doi.org/10.1111/jnc.12806">Publisher Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d29942e5126 class=n-a></a>Ghosh D, Sahay S, Ranjan P, <i> et al.</i>: The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates Î±-synuclein aggregation and membrane binding. <i>Biochemistry.</i> 2014; <b>53</b>(41): 6419â21. <a target=xrefwindow id=d29942e5137 href="http://www.ncbi.nlm.nih.gov/pubmed/25268550">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5140 href="http://dx.doi.org/10.1021/bi5010365">Publisher Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d29942e5149 class=n-a></a>Rutherford NJ, Giasson BI: The A53E Î±-synuclein pathological mutation demonstrates reduced aggregation propensity <i>in vitro</i> and in cell culture. <i>Neurosci Lett.</i> 2015; <b>597</b>: 43â8. <a target=xrefwindow id=d29942e5160 href="http://www.ncbi.nlm.nih.gov/pubmed/25892596">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5163 href="http://dx.doi.org/10.1016/j.neulet.2015.04.022">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5167 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4476064">Free Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d29942e5176 class=n-a></a>Porcari R, Proukakis C, Waudby CA, <i> et al.</i>: The H50Q mutation induces a 10-fold decrease in the solubility of Î±-synuclein. <i>J Biol Chem.</i> 2015; <b>290</b>(4): 2395â404. <a target=xrefwindow id=d29942e5187 href="http://www.ncbi.nlm.nih.gov/pubmed/25505181">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5190 href="http://dx.doi.org/10.1074/jbc.M114.610527">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5194 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4303689">Free Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a name=d29942e5203 class=n-a></a>Fares MB, Ait-Bouziad N, Dikiy I, <i> et al.</i>: The novel Parkinson's disease linked mutation G51D attenuates <i>in vitro</i> aggregation and membrane binding of Î±-synuclein, and enhances its secretion and nuclear localization in cells. <i>Hum Mol Genet.</i> 2014; <b>23</b>(17): 4491â509. <a target=xrefwindow id=d29942e5217 href="http://www.ncbi.nlm.nih.gov/pubmed/24728187">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5221 href="http://dx.doi.org/10.1093/hmg/ddu165">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5224 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4119404">Free Full Text </a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a name=d29942e5233 class=n-a></a>Ferreon AC, Moran CR, Ferreon JC, <i> et al.</i>: Alteration of the alpha-synuclein folding landscape by a mutation related to Parkinson's disease. <i>Angew Chem Int Ed Engl.</i> 2010; <b>49</b>(20): 3469â72. <a target=xrefwindow id=d29942e5244 href="http://www.ncbi.nlm.nih.gov/pubmed/20544898">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5247 href="http://dx.doi.org/10.1002/anie.201000378">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5251 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2972640">Free Full Text </a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d29942e5261 class=n-a></a>Rospigliosi CC, McClendon S, Schmid AW, <i> et al.</i>: E46K Parkinson's-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein. <i>J Mol Biol.</i> 2009; <b>388</b>(5): 1022â32. <a target=xrefwindow id=d29942e5272 href="http://www.ncbi.nlm.nih.gov/pubmed/19345692">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5275 href="http://dx.doi.org/10.1016/j.jmb.2009.03.065">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5279 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2719283">Free Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a name=d29942e5288 class=n-a></a>Bussell R Jr, Eliezer D: Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein. <i>J Biol Chem.</i> 2001; <b>276</b>(49): 45996â6003. <a target=xrefwindow id=d29942e5296 href="http://www.ncbi.nlm.nih.gov/pubmed/11590151">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5299 href="http://dx.doi.org/10.1074/jbc.M106777200">Publisher Full Text </a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727194875"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5308 class=n-a></a>Xu L, Ma B, Nussinov R, <i> et al.</i>: Familial Mutations May Switch Conformational Preferences in Î±-Synuclein Fibrils. <i>ACS Chem Neurosci.</i> 2017. <a target=xrefwindow id=d29942e5316 href="http://www.ncbi.nlm.nih.gov/pubmed/28075555">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5319 href="http://dx.doi.org/10.1021/acschemneuro.6b00406">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727194875">F1000 Recommendation</a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725332657"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5332 class=n-a></a>Sahay S, Ghosh D, Dwivedi S, <i> et al.</i>: Familial Parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of Î±-synuclein. <i>J Biol Chem.</i> 2015; <b>290</b>(12): 7804â22. <a target=xrefwindow id=d29942e5343 href="http://www.ncbi.nlm.nih.gov/pubmed/25635052">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5346 href="http://dx.doi.org/10.1074/jbc.M114.598607">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5350 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4367280">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725332657">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725941204"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5363 class=n-a></a>Acharya S, Saha S, Ahmad B, <i> et al.</i>: Effects of Mutations on the Reconfiguration Rate of Î±-Synuclein. <i>J Phys Chem B.</i> 2015; <b>119</b>(50): 15443â50. <a target=xrefwindow id=d29942e5374 href="http://www.ncbi.nlm.nih.gov/pubmed/26572968">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5377 href="http://dx.doi.org/10.1021/acs.jpcb.5b10136">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5381 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4836914">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725941204">F1000 Recommendation</a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727495797"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5394 class=n-a></a>Sanjeev A, Kumar Mattaparthi V: Computational Investigation on Tyrosine to Alanine Mutations Delaying the Early Stage of Î±-Synuclein Aggregation. <i>Curr Proteomics.</i> 2017; <b>14</b>(1): 31â41. <a target=xrefwindow id=d29942e5402 href="http://dx.doi.org/10.2174/1570164614666161206143325">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727495797">F1000 Recommendation</a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725428482"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5416 class=n-a></a>Chen SW, Drakulic S, Deas E, <i> et al.</i>: Structural characterization of toxic oligomers that are kinetically trapped during Î±-synuclein fibril formation. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(16): E1994â2003. <a target=xrefwindow id=d29942e5427 href="http://www.ncbi.nlm.nih.gov/pubmed/25855634">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5430 href="http://dx.doi.org/10.1073/pnas.1421204112">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5434 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4413268">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725428482">F1000 Recommendation</a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a name=d29942e5447 class=n-a></a>Xin W, Emadi S, Williams S, <i> et al.</i>: Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models. <i>Biomolecules.</i> 2015; <b>5</b>(3): 1634â51. <a target=xrefwindow id=d29942e5458 href="http://www.ncbi.nlm.nih.gov/pubmed/26287258">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5461 href="http://dx.doi.org/10.3390/biom5031634">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5465 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4598768">Free Full Text </a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718354192"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5474 class=n-a></a>Paslawski W, Mysling S, Thomsen K, <i> et al.</i>: Co-existence of two different Î±-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry. <i>Angew Chem Int Ed Engl.</i> 2014; <b>53</b>(29): 7560â3. <a target=xrefwindow id=d29942e5485 href="http://www.ncbi.nlm.nih.gov/pubmed/24740651">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5488 href="http://dx.doi.org/10.1002/anie.201400491">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718354192">F1000 Recommendation</a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725448763"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5501 class=n-a></a>Stefanovic AN, Lindhoud S, Semerdzhiev SA, <i> et al.</i>: Oligomers of Parkinson's Disease-Related Î±-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties. <i>Biochemistry.</i> 2015; <b>54</b>(20): 3142â50. <a target=xrefwindow id=d29942e5512 href="http://www.ncbi.nlm.nih.gov/pubmed/25909158">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5515 href="http://dx.doi.org/10.1021/bi501369k">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725448763">F1000 Recommendation</a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a name=d29942e5528 class=n-a></a>Gustot A, Gallea JI, Sarroukh R, <i> et al.</i>: Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease. <i>Biochem J.</i> 2015; <b>471</b>(3): 323â33. <a target=xrefwindow id=d29942e5539 href="http://www.ncbi.nlm.nih.gov/pubmed/26272943">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5542 href="http://dx.doi.org/10.1042/BJ20150617">Publisher Full Text </a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725934832"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5551 class=n-a></a>Deas E, Cremades N, Angelova PR, <i> et al.</i>: Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease. <i>Antioxid Redox Signal.</i> 2016; <b>24</b>(7): 376â91. <a target=xrefwindow id=d29942e5562 href="http://www.ncbi.nlm.nih.gov/pubmed/26564470">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5565 href="http://dx.doi.org/10.1089/ars.2015.6343">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5569 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4999647">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725934832">F1000 Recommendation</a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726381059"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5583 class=n-a></a>Oikawa T, Nonaka T, Terada M, <i> et al.</i>: Î±-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly. <i>J Biol Chem.</i> 2016; <b>291</b>(29): 15046â56. <a target=xrefwindow id=d29942e5594 href="http://www.ncbi.nlm.nih.gov/pubmed/27226637">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5597 href="http://dx.doi.org/10.1074/jbc.M116.736355">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5601 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4946922">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726381059">F1000 Recommendation</a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a name=d29942e5614 class=n-a></a>Bhak G, Lee J, Kim T, <i> et al.</i>: Molecular inscription of environmental information into protein suprastructures: temperature effects on unit assembly of Î±-synuclein oligomers into polymorphic amyloid fibrils. <i>Biochem J.</i> 2014; <b>464</b>(2): 259â69. <a target=xrefwindow id=d29942e5625 href="http://www.ncbi.nlm.nih.gov/pubmed/25203358">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5628 href="http://dx.doi.org/10.1042/BJ20140723">Publisher Full Text </a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a name=d29942e5637 class=n-a></a>Bousset L, Pieri L, Ruiz-Arlandis G, <i> et al.</i>: Structural and functional characterization of two alpha-synuclein strains. <i>Nat Commun.</i> 2013; <b>4</b>: 2575. <a target=xrefwindow id=d29942e5648 href="http://www.ncbi.nlm.nih.gov/pubmed/24108358">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5651 href="http://dx.doi.org/10.1038/ncomms3575">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3826637">Free Full Text </a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d29942e5664 class=n-a></a>Gath J, Bousset L, Habenstein B, <i> et al.</i>: Unlike twins: an NMR comparison of two Î±-synuclein polymorphs featuring different toxicity. <i>PLoS One.</i> 2014; <b>9</b>(3): e90659. <a target=xrefwindow id=d29942e5675 href="http://www.ncbi.nlm.nih.gov/pubmed/24599158">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5678 href="http://dx.doi.org/10.1371/journal.pone.0090659">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5682 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3944079">Free Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727053711"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e5691 class=n-a></a>Makky A, Bousset L, Polesel-Maris J, <i> et al.</i>: Nanomechanical properties of distinct fibrillar polymorphs of the protein Î±-synuclein. <i>Sci Rep.</i> 2016; <b>6</b>: 37970. <a target=xrefwindow id=d29942e5702 href="http://www.ncbi.nlm.nih.gov/pubmed/27901068">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5705 href="http://dx.doi.org/10.1038/srep37970">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5709 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5128817">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727053711">F1000 Recommendation</a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a name=d29942e5722 class=n-a></a>Melki R: Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases. <i>J Parkinsons Dis.</i> 2015; <b>5</b>(2): 217â27. <a target=xrefwindow id=d29942e5730 href="http://www.ncbi.nlm.nih.gov/pubmed/25757830">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5733 href="http://dx.doi.org/10.3233/JPD-150543">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5736 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4923763">Free Full Text </a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d29942e5746 class=n-a></a>Paravastu AK, Leapman RD, Yau WM, <i> et al.</i>: Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(47): 18349â54. <a target=xrefwindow id=d29942e5757 href="http://www.ncbi.nlm.nih.gov/pubmed/19015532">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5760 href="http://dx.doi.org/10.1073/pnas.0806270105">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5764 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2587602">Free Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a name=d29942e5773 class=n-a></a>Petkova AT, Leapman RD, Guo Z, <i> et al.</i>: Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. <i>Science.</i> 2005; <b>307</b>(5707): 262â5. <a target=xrefwindow id=d29942e5784 href="http://www.ncbi.nlm.nih.gov/pubmed/15653506">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5787 href="http://dx.doi.org/10.1126/science.1105850">Publisher Full Text </a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a name=d29942e5796 class=n-a></a>Makarava N, Savtchenko R, Alexeeva I, <i> et al.</i>: New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions. <i>Am J Pathol.</i> 2016; <b>186</b>(4): 1006â14. <a target=xrefwindow id=d29942e5807 href="http://www.ncbi.nlm.nih.gov/pubmed/26873446">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5810 href="http://dx.doi.org/10.1016/j.ajpath.2015.11.013">Publisher Full Text </a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a name=d29942e5819 class=n-a></a>Sano K, Atarashi R, Ishibashi D, <i> et al.</i>: Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion. <i>J Virol.</i> 2014; <b>88</b>(20): 11791â801. <a target=xrefwindow id=d29942e5830 href="http://www.ncbi.nlm.nih.gov/pubmed/25078700">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5833 href="http://dx.doi.org/10.1128/JVI.00585-14">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5837 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4178718">Free Full Text </a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a name=d29942e5846 class=n-a></a>Solforosi L, Milani M, Mancini N, <i> et al.</i>: A closer look at prion strains: characterization and important implications. <i>Prion.</i> 2013; <b>7</b>(2): 99â108. <a target=xrefwindow id=d29942e5857 href="http://www.ncbi.nlm.nih.gov/pubmed/23357828">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5860 href="http://dx.doi.org/10.4161/pri.23490">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5864 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3609129">Free Full Text </a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a name=d29942e5873 class=n-a></a>Morales R, Abid K, Soto C: The prion strain phenomenon: molecular basis and unprecedented features. <i>Biochim Biophys Acta.</i> 2007; <b>1772</b>(6): 681â91. <a target=xrefwindow id=d29942e5881 href="http://www.ncbi.nlm.nih.gov/pubmed/17254754">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5884 href="http://dx.doi.org/10.1016/j.bbadis.2006.12.006">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5887 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2597801">Free Full Text </a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a name=d29942e5897 class=n-a></a>Wickner RB: Yeast and Fungal Prions. <i>Cold Spring Harb Perspect Biol.</i> 2016; <b>8</b>(9): pii: a023531. <a target=xrefwindow id=d29942e5905 href="http://www.ncbi.nlm.nih.gov/pubmed/27481532">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5908 href="http://dx.doi.org/10.1101/cshperspect.a023531">Publisher Full Text </a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a name=d29942e5917 class=n-a></a>Sharma A, Bruce KL, Chen B, <i> et al.</i>: Contributions of the Prion Protein Sequence, Strain, and Environment to the Species Barrier. <i>J Biol Chem.</i> 2016; <b>291</b>(3): 1277â88. <a target=xrefwindow id=d29942e5928 href="http://www.ncbi.nlm.nih.gov/pubmed/26565023">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5931 href="http://dx.doi.org/10.1074/jbc.M115.684100">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4714215">Free Full Text </a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a name=d29942e5944 class=n-a></a>Toyama BH, Kelly MJ, Gross JD, <i> et al.</i>: The structural basis of yeast prion strain variants. <i>Nature.</i> 2007; <b>449</b>(7159): 233â7. <a target=xrefwindow id=d29942e5955 href="http://www.ncbi.nlm.nih.gov/pubmed/17767153">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5958 href="http://dx.doi.org/10.1038/nature06108">Publisher Full Text </a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a name=d29942e5967 class=n-a></a>Arvidsson S, Pilebro B, Westermark P, <i> et al.</i>: Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition. <i>PLoS One.</i> 2015; <b>10</b>(11): e0143456. <a target=xrefwindow id=d29942e5978 href="http://www.ncbi.nlm.nih.gov/pubmed/26600306">PubMed Abstract </a> | <a target=xrefwindow id=d29942e5981 href="http://dx.doi.org/10.1371/journal.pone.0143456">Publisher Full Text </a> | <a target=xrefwindow id=d29942e5985 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4658178">Free Full Text </a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a name=d29942e5994 class=n-a></a>Sneideris T, Darguzis D, Botyriute A, <i> et al.</i>: pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils. <i>PLoS One.</i> 2015; <b>10</b>(8): e0136602. <a target=xrefwindow id=d29942e6005 href="http://www.ncbi.nlm.nih.gov/pubmed/26313643">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6008 href="http://dx.doi.org/10.1371/journal.pone.0136602">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6012 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4551895">Free Full Text </a></span></li><li><a name=ref-191 class=n-a></a><span class=label>191. </span>&nbsp;<span class=citation><a name=d29942e6021 class=n-a></a>Kodali R, Williams AD, Chemuru S, <i> et al.</i>: Abeta(1â40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. <i>J Mol Biol.</i> 2010; <b>401</b>(3): 503â17. <a target=xrefwindow id=d29942e6032 href="http://www.ncbi.nlm.nih.gov/pubmed/20600131">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6035 href="http://dx.doi.org/10.1016/j.jmb.2010.06.023">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2919579">Free Full Text </a></span></li><li><a name=ref-192 class=n-a></a><span class=label>192. </span>&nbsp;<span class=citation><a name=d29942e6049 class=n-a></a>Morales R, Callegari K, Soto C: Prion-like features of misfolded AÎ² and tau aggregates. <i>Virus Res.</i> 2015; <b>207</b>: 106â12. <a target=xrefwindow id=d29942e6057 href="http://www.ncbi.nlm.nih.gov/pubmed/25575736">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6060 href="http://dx.doi.org/10.1016/j.virusres.2014.12.031">Publisher Full Text </a></span></li><li><a name=ref-193 class=n-a></a><span class=label>193. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725547363"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e6069 class=n-a></a>Peelaerts W, Bousset L, Van der Perren A, <i> et al.</i>: Î±-Synuclein strains cause distinct synucleinopathies after local and systemic administration. <i>Nature.</i> 2015; <b>522</b>(7556): 340â4. <a target=xrefwindow id=d29942e6080 href="http://www.ncbi.nlm.nih.gov/pubmed/26061766">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6083 href="http://dx.doi.org/10.1038/nature14547">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725547363">F1000 Recommendation</a></span></li><li><a name=ref-194 class=n-a></a><span class=label>194. </span>&nbsp;<span class=citation><a name=d29942e6096 class=n-a></a>Lerner A, Bagic A: Olfactory pathogenesis of idiopathic Parkinson disease revisited. <i>Mov Disord.</i> 2008; <b>23</b>(8): 1076â84. <a target=xrefwindow id=d29942e6104 href="http://www.ncbi.nlm.nih.gov/pubmed/18442121">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6107 href="http://dx.doi.org/10.1002/mds.22066">Publisher Full Text </a></span></li><li><a name=ref-195 class=n-a></a><span class=label>195. </span>&nbsp;<span class=citation><a name=d29942e6116 class=n-a></a>Visanji NP, Brooks PL, Hazrati LN, <i> et al.</i>: The prion hypothesis in Parkinson's disease: Braak to the future. <i>Acta Neuropathol Commun.</i> 2013; <b>1</b>: 2. <a target=xrefwindow id=d29942e6127 href="http://www.ncbi.nlm.nih.gov/pubmed/24252164">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6130 href="http://dx.doi.org/10.1186/2051-5960-1-2">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6134 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3776210">Free Full Text </a></span></li><li><a name=ref-196 class=n-a></a><span class=label>196. </span>&nbsp;<span class=citation><a name=d29942e6143 class=n-a></a>Ulusoy A, Musgrove RE, Rusconi R, <i> et al.</i>: Neuron-to-neuron Î±-synuclein propagation <i>in vivo</i> is independent of neuronal injury. <i>Acta Neuropathol Commun.</i> 2015; <b>3</b>: 13. <a target=xrefwindow id=d29942e6157 href="http://www.ncbi.nlm.nih.gov/pubmed/25853980">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6161 href="http://dx.doi.org/10.1186/s40478-015-0198-y">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6164 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4369863">Free Full Text </a></span></li><li><a name=ref-197 class=n-a></a><span class=label>197. </span>&nbsp;<span class=citation><a name=d29942e6173 class=n-a></a>Tofaris GK, Goedert M, Spillantini MG: The Transcellular Propagation and Intracellular Trafficking of Î±-Synuclein. <i>Cold Spring Harb Perspect Med.</i> 2016; pii: a024380. <a target=xrefwindow id=d29942e6178 href="http://www.ncbi.nlm.nih.gov/pubmed/27920026">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6181 href="http://dx.doi.org/10.1101/cshperspect.a024380">Publisher Full Text </a></span></li><li><a name=ref-198 class=n-a></a><span class=label>198. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726794605"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d29942e6191 class=n-a></a>Mao X, Ou MT, Karuppagounder SS, <i> et al.</i>: Pathological Î±-synuclein transmission initiated by binding lymphocyte-activation gene 3. <i>Science.</i> 2016; <b>353</b>(6307): pii: aah3374. <a target=xrefwindow id=d29942e6202 href="http://www.ncbi.nlm.nih.gov/pubmed/27708076">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6205 href="http://dx.doi.org/10.1126/science.aah3374">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726794605">F1000 Recommendation</a></span></li><li><a name=ref-199 class=n-a></a><span class=label>199. </span>&nbsp;<span class=citation><a name=d29942e6218 class=n-a></a>Illes-Toth E, Ramos MR, Cappai R, <i> et al.</i>: Distinct higher-order Î±-synuclein oligomers induce intracellular aggregation. <i>Biochem J.</i> 2015; <b>468</b>(3): 485â93. <a target=xrefwindow id=d29942e6229 href="http://www.ncbi.nlm.nih.gov/pubmed/25851527">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6232 href="http://dx.doi.org/10.1042/BJ20150159">Publisher Full Text </a></span></li><li><a name=ref-200 class=n-a></a><span class=label>200. </span>&nbsp;<span class=citation><a name=d29942e6241 class=n-a></a>SchlÃ¼ter H, Apweiler R, HolzhÃ¼tter H, <i> et al.</i>: Finding one's way in proteomics: a protein species nomenclature. <i>Chem Cent J.</i> 2009; <b>3</b>: 11. <a target=xrefwindow id=d29942e6252 href="http://www.ncbi.nlm.nih.gov/pubmed/19740416">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6255 href="http://dx.doi.org/10.1186/1752-153X-3-11">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6259 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2758878">Free Full Text </a></span></li><li><a name=ref-201 class=n-a></a><span class=label>201. </span>&nbsp;<span class=citation><a name=d29942e6268 class=n-a></a>Smith LM, Kelleher NL: Proteoform: a single term describing protein complexity. <i>Nat Methods.</i> 2013; <b>10</b>(3): 186â7. <a target=xrefwindow id=d29942e6276 href="http://www.ncbi.nlm.nih.gov/pubmed/23443629">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6279 href="http://dx.doi.org/10.1038/nmeth.2369">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6282 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4114032">Free Full Text </a></span></li><li><a name=ref-202 class=n-a></a><span class=label>202. </span>&nbsp;<span class=citation><a name=d29942e6291 class=n-a></a>Uversky VN: p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum Concept. <i>Int J Mol Sci.</i> 2016; <b>17</b>(11): pii: E1874. <a target=xrefwindow id=d29942e6299 href="http://www.ncbi.nlm.nih.gov/pubmed/27834926">PubMed Abstract </a> | <a target=xrefwindow id=d29942e6302 href="http://dx.doi.org/10.3390/ijms17111874">Publisher Full Text </a> | <a target=xrefwindow id=d29942e6305 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5133874">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Apr 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-525&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-525&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Molecular Medicine and USF Health Byrd Alzheimer&#700;s Research Institute, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd. MDC07, Tampa, FL, 33620, USA<br/> <sup>2</sup> Laboratory of New Methods in Biology, Institute for Biological Instrumentation, Russian Academy of Sciences, 7 Institutskaya St., 142290 Pushchino, Moscow Region, Russian Federation<br/> <sup>3</sup> Laboratory of Structural Dynamics, Stability and Folding Of Proteins, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Av., 194064 St. Petersburg, Russian Federation<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-525/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 Apr 2017, 6:525 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10536.1">https://doi.org/10.12688/f1000research.10536.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> Â© 2017 Uversky VN. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11354 data-id=10536 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10536.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-525/v1/pdf?article_uuid=d6568425-7311-4634-8f5c-e3df37bf807f" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10536.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Uversky VN. Looking at the recent advances in understanding Î±-synuclein and its aggregation through the proteoform prism [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):525 (<a href="https://doi.org/10.12688/f1000research.10536.1" target=_blank>https://doi.org/10.12688/f1000research.10536.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10536 id=mobile-track-article-signin-10536 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10536?target=/articles/6-525"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11354 /> <input name=articleId type=hidden value=10536 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Vinod Subramaniam</strong>, Vrije Universiteit Amsterdam, The Netherlands </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Hilal Lashuel</strong>, Brain Mind Institute, Ecole Polytechnique FÃ©dÃ©rale de Lausanne (EPFL), Switzerland </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Apr 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-525&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-525&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20882-20585></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20883-20584></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-525/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 Apr 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Vinod Subramaniam</strong>, Vrije Universiteit Amsterdam, The Netherlands </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Hilal Lashuel</strong>, Brain Mind Institute, Ecole Polytechnique FÃ©dÃ©rale de Lausanne (EPFL), Switzerland </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-525&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-525/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Looking at the recent advances in understanding...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-525/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-525/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-525/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Uversky VN');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-525/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-525",
            templates : {
                twitter : "Looking at the recent advances in understanding \u03B1-synuclein.... Uversky VN, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-525/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Looking at the recent advances in understanding \u03B1-synuclein and its aggregation through the proteoform prism", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Looking at the recent advances in understanding \u03B1-synuclein and its aggregation through the proteoform prism", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10536/11354")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11354");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "20584": 0,
                           "20585": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "afd3be9b-ad10-40f9-9408-24a585dc0703";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-525.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-525.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-525.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-525.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-525.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>